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Low-dose effects of Bisphenol A on human primary vascular 
endothelial cells and colon cancer cells 
 
Abstract 
 
Bisphenol A (BPA) is an extensively utilized endocrine disruptor for which 
human exposure is considered generalized through ingestion. Information 
regarding BPA effects on vascular and digestive tract tissues is scarce. 
Therefore, in this work primary Human Umbilical Vein Endothelial Cells 
(HUVEC) and human colon adenocarcinona cell line HT29 were used to 
evaluate BPA effects at two distinct low-dose concentrations relevant in terms 
of human health risk assessment.     
BPA differentially affects the cell types studied, with more pronounced 
aneugenic effects, nucleolar disruption and transcriptional deregulation 
observed in HUVEC. Prolonged BPA exposure affects aging processes in 
senescent HUVEC. Interaction experiments involving expression of key cancer 
related genes shows that BPA antagonizes transcriptional effects of the 
chemotherapeutic agent doxorubicin in HT29. Additionally BPA aneugenic 
effects are enhanced by co-exposure with Eupatorium cannabinum L. ethanolic 
extract, a medicinal plant, for which a potent cytotoxic activity against HT29 
cells is also demonstrated here. 
Altogether these results support increasing concerns regarding harmful effects 
of BPA at low-dose on human health and draw attention to the importance of a 
deeper understanding of BPA potential interactions with other chemicals. 
 
Key-words: Bisphenol A (BPA), HUVEC, HT29, Gene transcription, Drug 
interaction.  
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 Efeitos de doses baixas de Bisfenol A em células endoteliais 
vasculares primárias e em células de cancro de cólon humanas 
 
Resumo 
 
O bisfenol A (BPA) é um desregulador endócrino amplamente utilizado para o 
qual a exposição humana é considerada generalizada através de ingestão. A 
informação sobre os efeitos do BPA nos tecidos vasculares e digestivos é no 
entanto reduzida. Assim, neste trabalho foram utilizadas células endoteliais da 
veia do cordão umbilical humanas (HUVEC) e uma linha celular de 
adenocarcinoma de cólon HT29 para avaliar os efeitos de duas concentrações 
de BPA, consideradas doses baixas e relevantes para avaliação de risco para a 
saúde humana. 
No que respeita à indução de aneugenia, alterações nucleolares e 
desregulação da transcrição génica foram observados efeitos mais 
pronunciados do BPA em HUVEC comparativamente com HT29. A exposição 
prolongada ao BPA interfere com o processo de envelhecimento em células 
HUVEC. A avaliação de interações em HT29 revelou um efeito antagonista do 
BPA, na transcrição de genes associados ao cancro, relativamente ao agente 
quimioterapêutico doxorrubicina. Também em HT29 foi observado um aumento 
dos efeitos aneugénicos do BPA após exposição conjunta com extrato 
etanólico da planta medicinal Eupatorium cannabinum L., para o qual foi 
também demonstrada uma potente atividade citotóxica.  
Os resultados obtidos suportam a crescente preocupação com os efeitos 
nocivos do BPA na saúde humana e acentuam importância de uma avaliação 
aprofundada das possíveis interações do BPA com outros compostos químicos.  
  
Palavras-chave: Bisfenol A (BPA), HUVEC, HT29, Transcrição génica, 
Interação entre compostos químicos.  
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Preamble 
 
 
Bisphenol A (BPA) is one of the greatest endocrine disruptor chemicals 
produced worldwide, employed in a wide variety of consumer products including 
food and drink containers. Human exposure to BPA through oral intake is 
considered generalized, at least in developed countries. However the levels of 
BPA internal exposure and its potential harmful outcomes to human health are 
still controversial. Extensive research in human cell lines, particularly from sex 
hormone responsive tissues, show that BPA can endorse very distinct cellular 
responses through estrogen receptor signalling pathways. Although BPA is 
absorbed in the gut and enters blood circulation, its effects on cells from 
digestive or vascular systems are largely unknown.  
Therefore, in this research project two distinct cell types: Human Umbilical Vein 
Endothelial Cells (HUVEC), an in vitro model for vascular cells, and the human 
cell line HT29, originated from a colon adenocarcinona, the most common type 
of gastrointestinal cancer were utilized. Two BPA concentrations (44 nM and 
4.4 µM), relevant in the context of risk assessment, were selected for evaluation 
of cellular proliferation and viability, aneugenic capacity, nucleolar organization 
and gene transcription in both cell types. Considering that distinct 
epidemiological studies correlate circulating BPA levels with age-related 
vascular diseases HUVEC were used to assess the effects of BPA prolonged 
exposure on aging cells. Furthermore there are some evidences that the action 
of chemotherapeutic drugs can be antagonized by BPA. Hence this work aimed 
also to evaluate in HT29 cells potential interactions of BPA with Doxorubicin 
(DOX), commonly used in chemotherapy, as well as with the extract of 
Eupatorium cannabinum L., a plant utilized in alternative medicine for treatment 
of several pathologies including cancer.  
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1 Introduction 
 
Bisphenol A (BPA), 2,2-bis(4-hydroxyphenyl) propane is an organic compound 
and one of the greatest volume industrial chemicals utilized in the world, with a 
production 4.6 million tonnes in 2012 (MRC 2014). BPA was first synthesized by 
A. P. Dianin in 1891 and its estrogenic properties were hypothesized in the 
search for synthetic estrogens in the 1930s, however BPA was abandoned for 
pharmaceutical use when Diethylstilbestrol (DES) was found to be more 
efective (reviwed in Vandenberg et al. 2009). Since 1940, BPA has been 
extensively used in the production of a variety of polymers such as 
polycarbonate plastics and epoxy resins and therefore employed in the 
manufacture of a variety of indoor applications and consumer products (Geens 
et al. 2011). In the 60´s several studies emerged focused on the hypersensitivity 
and metabolism of BPA in different model systems (Fregert and Rorsman 1962; 
Gaul 1960; Knaak and Sullivan 1966) and since then extensive research has 
been conducted on the effects of this endocrine disrupting chemical (EDC) in 
both animals and humans (reviewed in Rochester 2013; Vandenberg et al. 
2009). Importantly, in 1993 Krishnan and coworkers accidentally discovered 
that BPA leaches from autoclaved polycarbonate flasks and showed for the first 
time its positive effect on the proliferation rate of the human cell line MCF-7 
(Krishnan et al. 1993). In 2001 the United States National Toxicology Program’s 
Report of the Endocrine Disruptors Low-Dose Peer Review recognized that 
there was credible but not conclusive evidence that low doses of BPA can 
cause effects on specific endpoints (NTP 2001). Since 2006, the European 
Food Safety Authority (EFSA) conducted several scientific assessments on 
BPA, repeatedly concluding that there is no concern for human health (EFSA 
2014). However in 2011 the European Legislation banned the use of BPA in the 
manufacture of baby bottles (EC 2011) and in 2012 EFSA decided to carry out 
a new risk assessment of BPA that is currently in progress (EFSA 2014).  
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1.1 Human exposure and biomonitoring  
 
Environmental human exposure to BPA is considered a generalized 
phenomenon, at least in developed countries, since analysis of tissue and fluid 
samples reveal the presence of BPA in the majority of the individuals analysed 
(Geens et al. 2012). Ingestion of contaminated food is estimated to contribute 
with more than 90% to the overall BPA environmental exposure for all age 
groups and a recent intervention study showed that the removal of packed food 
from diet results in a significant reduction of urine BPA levels (Rudel et al. 
2011). Non-dietary sources, such as air or contact, are generally considered to 
be significant only for occupationally exposed individuals (Geens et al. 2012). In 
2004 the European Legislation established the specific migration limit (SML) for 
BPA on plastic materials and articles intended to come into contact with food at 
0.6 mg/kg food (EC 2004). This SML value was based on an adult average 
body of 60 kg, the consumption 1 kg of food, and a tolerable daily intake (TDI) 
of 0.01 mg/kg bw (EC 2002). Although the TDI value was later raised to 0.05 
mg/kg bw due to the elimination of an uncertainty factor of 5 concerning 
reproduction and development (EFSA 2006, 2010), the SML value was not 
altered. The actual TDI for BPA was derived from a comprehensive tree-
generation study in rats with a No Observable Adverse Effect Level (NOAEL) of 
5 mg/kg body weight/day and the application of uncertainty factor of 100 (10 for 
inter-species differences, 10 for inter-individual differences) (Tyl et al. 2002). 
This value corresponds also to BPA oral reference dosage (RfD) established by 
the U.S. Environmental Protection Agency (EPA) (EPA 1993) based on a rat 
chronic toxicity study regarding mean body weight  with a Lowest Observable 
Adverse Effect Level (LOAEL) of 50 mg/kg body weight/day considering an 
uncertainty factor of 1000 (10 for inter-species differences, 10 for inter-individual 
differences and 10 for the uncertainty of duration of the toxic effects) (NTP 
1982). 
Human exposure to BPA has been estimated either by direct measurement on 
human biological samples or from dietary studies where concentrations in food 
and beverages were measured and aggregate exposure derived from food and 
water consumption data (reviewed in Sekizawa 2008). For the past years 
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urinary concentrations of total (free and conjugated) BPA have been evaluated 
in order to assess BPA exposure as the matrix of choice for biomonitoring 
studies (Calafat et al. 2008; Vandenberg et al. 2010). The most recent 
worldwide biomonitoring study base on data from urinary BPA concentrations 
estimated human exposure to be 0.27 µg/kg body weight/day for the general 
population, 0.78 µg/kg body weight/day for children and 0.45-1.61 µg/kg body 
weight/day for infants (WHO 2010). Moreover the scientific EFSA panel on 
“food additives, flavourings, processing aids and materials in contact with food” 
assumed more conservative scenarios and estimated that human exposure to 
BPA is in average of 1.5 µg/kg body weight/day (EFSA 2006). These results 
correspond to approximately 100 to 10 fold less than the TDI. Accordingly data 
from urinary excretion also estimate the daily intake of BPA at levels 
considerably lower than the TDI. Urinary excretion data analysis on US 
population survey NHANES 2005-2006 resulted in median intake levels of 
0.032–0.036 µg/kg body weight/day with a upper level of 0.255 µg/kg body 
weight/day (Lakind and Naiman 2010). Identical values where also obtained 
through the compilation of distinct independent studies (Geens et al. 2012). 
However, these values are still controversial since biomonitoring data from non-
urinary human samples point to higher human BPA exposure. Considerably 
high concentrations of BPA have been measured in human placental samples 
as well as in fetal serum indicating that the placenta does not work as a barrier 
to BPA and therefore that human developing fetuses are chronically exposed to 
BPA (Schonfelder et al. 2002). Accordingly, several inconsistencies have also 
been described between the estimate intake levels and biomonitoring studies 
performed in human blood/serum samples. These studies demonstrate that the 
long term daily intake of BPA leads to a steady-state presence of 
unmetabolized BPA in the range of 0.5–3 ng/ml (2–13 nM) (Vandenberg et al. 
2007; 2010), which is about 10-fold higher than the worst case predictions for 
daily human exposure to BPA (Völkel et al. 2002). Also physiologically based 
model studies estimate that for adult humans these levels of unmetabolized 
BPA in blood would require dosages considerably higher than the TDI (Edginton 
and Ritter 2009; Fisher et al. 2011). Overall this suggests that either BPA intake 
is higher than estimated or that this chemical bioaccumulates in the body.  
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On the other hand, for the past years epidemiological studies have established 
positive correlations between urinary or blood BPA concentrations and the 
prevalence of recurrent human diseases. These include thyroid hormone 
disruption (Wang et al. 2013); reproductive malfunctions (Ehrlich et al. 2012; Li 
et al. 2011),  type-2 diabetes mellitus (Silver et al. 2011), obesity (Trasande et 
al., 2012) and pathogenesis of age-related diseases such as coronary and 
carotid atherosclerosis (Lind and Lind 2011; Melzer et al. 2010; Melzer et al. 
2012).  
1.2 Metabolism and toxicokinetics 
 
The metabolism and toxicokinetics of BPA has been studied in rodents (Doerge 
et al. 2010a, 2011), non-human primates  (Doerge et al. 2010b; 2011) and 
humans (Völkel et al. 2002; 2005). After ingestion, BPA is absorbed from the 
gastrointestinal tract and undertakes a rapid phase II metabolism in the gut and 
liver. BPA is extensively conjugated with glucuronic acid to BPA-glucuronide 
resulting in loss of estrogenic activity and consequent low circulating levels of 
active (free) BPA (Hengstler et al. 2011). Although BPA glucuronidation is the 
primary mode of phase II metabolism in both rodents and primates there are 
some differences regarding excretion. In primates, including humans, blood 
BPA clearance occurs in the kidney and BPA-glucuronide represents the major 
BPA component in urine (Fisher et al. 2011; Tominaga et al. 2006). In contrast 
in rodents the conjugated BPA undergoes enterohepatic recirculation and fecal 
excretion via bile (Pottenger et al. 2000). It has been suggested that this 
difference can result in higher internal exposure in rodents due to longer 
elimination time and this argument was used to maintain the TDI level based on 
NOAEL obtained in rats since an uncertainty factor of 100 was considered 
conservative (EFSA 2008). Nevertheless there are evidences that regardless of 
the route of excretion the bioavailability of BPA is similar in rodents and 
primates (Taylor et al. 2011; Uchida et al. 2002).  
Evaluation of BPA excretion kinetic profile in a limited number of human 
volunteers subjected to a single oral dose of deuterated BPA revealed a rapid 
peak and a terminal half-life of less than 6 hours (Völkel et al. 2002; 2005). This 
data has been interpreted as indicating a rapid and complete BPA clearance in 
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humans. However, large-scale biomonitoring data revealed that urine BPA 
levels do not decline rapidly with fasting time suggesting a longer BPA 
clearance (Stahlhut et al. 2009) what is also supported by the fact that in the 
2002 Volkel study no significant removal of conjugated BPA was detected 
beyond 20 h of exposure (Teeguarden et al. 2005). The occurrence of BPA-
glucuronide deconjugation by β-glucuronidases in specific organs and 
consequent conjugation–deconjugation cycling has been suggested as an 
explanation for the delayed excretion (reviewed in Ginsberg and Rice 2009; 
Vandenberg et al. 2009). Additionally, single oral bolus experiments may 
underestimate exposure to bioactive form of BPA. Steady state internal BPA 
concentrations in humans were predicted to occur in continuous exposure 
trough diet (Mielke and Gundert-Remy 2009) and in mice it was shown that 
BPA bioavailability for equivalent BPA dosages is lower for a single oral bolus 
administration than in continuous exposure through food (Sieli et al. 2011).  
1.3 Mechanisms of action as an EDC 
 
Although BPA estrogenic activity has long been acknowledged, it has been 
considered a weak estrogen due to the fact that its binding affinity to classical 
estrogen receptors α and β (ERα and ERβ) is 10,000- and 1,000-fold lower than 
that of endogenous estrogen estradiol (E2) for ERα and ERβ, respectively 
(Routledge et al. 2000). However, distinct studies have shown that BPA can 
promote estrogen-like effects similar or stronger than E2. BPA at a dose range 
of 0.1-1 nM was shown to be equally effective, or even more effective, than 
equimolar concentrations of E2 in suppressing adiponectin release from human 
adipose tissues (Hugo et al. 2008). In BG-1 ovarian cancer cells both BPA and 
E2 induce cellular proliferation by promoting the interaction between ERα and 
IGF-1R signaling pathways (Hwang et al. 2013b). BPA induction of alternative 
signaling pathways is as well a possible explanation for the paradigm of E2 and 
BPA equivalent effects. Interestingly, BPA binds to the orphan nuclear receptor 
estrogen-related receptor-γ (ERR-γ) (Matsushima et al. 2007) with 80-100 times 
higher affinity than for ERα or ERβ  (Takayanagi et al. 2006; Thomas and Dong 
2006). Also activation of membrane-bound variants of ERs, particularly ERα, 
that act outside the nucleus was been suggested as a possible BPA mode of 
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action (reviewed in Alonso-Magdalena et al. 2012). Additionally, cellular 
responses to BPA at low concentrations have been correlated with the trans-
membrane estrogen receptor G protein-coupled estrogen receptor (GPR30 or 
GPER) for which BPA has relative high affinity corresponding to 2.8% of that of 
E2 (Shanle and Xu 2010; Thomas and Dong 2006). BPA induces rapid 
activation of ERK signaling pathway through GPR30 in breast cancer cells and 
cancer-associated fibroblasts (Dong et al. 2010) resulting in increased cell 
proliferation and migration (Pupo et al. 2012). Hence BPA can affect gene 
transcription trough nuclear and membrane-bound estrogen receptors. On the 
other hand, it is worth noting that hormones and EDCs, including BPA, 
responses do follow non-monotonic dose responses (NMDR) curves. In the 
case of BPA NMDR were demonstrated to emerge on exposed pituitary, 
prostate and pancreatic cultured cells, since very low doses can induce 
significant effects that are not detectable at higher concentrations (reviewed in 
Vandenberg et al. 2012).  
1.4 Low doses effects on human cells  
 
BPA concentrations (equal or greater than 100 µM) are genotoxic and result in 
a severe decrease of cellular proliferation and viability (Bolli et al. 2008; Kim et 
al. 2007). Additionally BPA in a range of 50-200 µM directly interferes with 
mechanisms of cell division by targeting tubulin promoting microtubular 
polymerization, which results in the formation of multiplolar spindles in HeLa 
cells (George et al. 2008). BPA genotoxic aneugenic properties characterized 
by micronuclei formation was also reported in human lymphoblastoid cell lines 
such as AHH-1 with a dose range of 54.12-162.8 µM (Johnson and Parry 2008) 
as well as in MCL-5 at 22-132 µM and further associated with chromosome 
non-disjunction for the concentration range of 22-88 µM (Parry et al. 2002). On 
the other hand, similar genotoxic effects have been describe for both BPA and 
E2 in MCF-7 cells although achieved with 1000-fold higher doses of BPA than 
the natural hormone (Iso et al. 2006). Also in CHO-K1 cells E2 induces 
chromosome aberrations and aneuploidgenic effects at 250 µM and 50 µM 
concentrations respectively, whereas BPA had the same effects for 400 µM and 
500 µM (Tayama et al. 2008).  
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However, and considering the level of BPA exposure on human cells in vivo, the 
“low-dose” effects have been a focal point of numerous studies (reviewed in 
Sekizawa 2008; Teeguarden and Hanson-Drury 2013; Vandenberg et al. 2009; 
2012). BPA “low-dose” effects were defined as biological changes occuring in 
the concentration range of typical human exposures or lower than the expected 
NOAEL level of 5000 µg/kg/day, used to establish the oral reference dosage 
(RfD) (NTP 2001). However a recent review demonstrated that the majority of in 
vivo and in vitro toxicity studies have been performed within the BPA 
concentration range of 0.1 nM to 10 µM (Teeguarden and Hanson-Drury 2013). 
In vitro cell systems have been widely used in the assessment of low-dose BPA 
effects however most studies have been directed to human cancer cell lines, 
particularly breast cancer revealing effects on proliferation and gene expression 
(reviewed in Vandenberg et al. 2012; Wetherill et al. 2007). It has been recently 
demonstrated that BPA have direct effects in vascular endothelial function 
(Andersson and Brittebo 2012) and acts as an E2 antagonist in colon cancer 
cells (Bolli et al. 2010). Nonetheless, the effects of environmental relevant levels 
of BPA in human vascular endothelial cells and digestive tract cells are mostly 
unknown, although these types of cells are in direct contact to BPA in vivo. 
1.4.1 Cell proliferation and viability 
 
Several studies that evaluate proliferation and viability effects of low BPA 
concentrations in human cells cultures reveal cell type specificities. While some 
cell types show a positive response to BPA (LaPensee et al. 2009; Ptak et al. 
2011; Ricupito et al. 2009) in others no measurable effect is detected (Bolli et 
al. 2008; Kim et al. 2007; LaPensee et al. 2009). The divergence of the results 
has been correlated with distinct signaling pathways. BPA proliferative effects at 
concentrations as low as 1 nM, have been reported in ERα-positive human cell 
lines such as breast cancer MCF-7cell lines (Ricupito et al. 2009), human ductal 
breast epithelial tumor cell line (T47D) (LaPensee et al. 2009) and human 
ovarian carcinoma cell line (OVCAR-3) (Ptak et al. 2011). Accordingly, 
unresponsiveness to BPA was observed in ERα-negative ERβ-positive cell lines 
such as cervical cancer HeLa cells (Bolli et al., 2008) or breast cancer MDA-
MB-468 cells (Bolli et al. 2008; LaPensee et al. 2009). However, in SK-N-SH 
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neuroblastoma cells, also ERα-negative and ERβ-positive, increased 
proliferation induced by BPA (10 µM) was shown to be mediated by ERβ and 
associated with altered transcriptional levels of cell cycle-related genes (Zhu et 
al. 2009). On the other hand, in ERβ positive and ERα negative human 
testicular cancer cell line JKT-1, signaling through the membrane bound 
GPR30 receptor results in enhanced cell proliferation for BPA concentrations 
ranging from 1 pM to 10 µM, (Bouskine et al. 2009).  
Cell proliferation can be naturally disrupted in the aging process with loss of 
replicative capacity which is associated with alterations in cell structure and 
physiology (Debacq-Chainiaux et al. 2008; Hwang et al. 2009). A similar 
phenotype can also be observed after cell exposure to subcytotoxic doses of 
stressful agents in a process described as stress-induced premature 
senescence (Dumont et al. 2002; Toussaint et al. 2000) characterized by cell-
type dependent alterations in cellular gene expression profiles (Debacq-
Chainiaux et al. 2008; Shelton et al. 1999). A recent study revealed that BPA 
(10-100 nM) may enhance senescence in normal human mammary epithelial 
cells (HMEC), associated to deregulation of cell cycle regulatory genes (Qin et 
al. 2012). However, despite the knowledge that humans are in continuous 
contact to BPA in vivo, its effects on cellular aging processes remain largely 
unknown. On the other hand, EDCs and particularly BPA exposure has been 
positively correlated with decreased semen quality and male infertility, for which 
induction of germ cell apoptosis is considered a primary contributing factor 
(reviewed in Lagos-Cabre and Moreno 2012). BPA-induced apoptosis was also 
observed in human trophoblastic cells in vitro for a concentration of 1 µM 
(Morice et al. 2011) as well as in rat ovarian cells in vivo after prolonged 
exposure (Lee et al. 2013), indicating a potential negative role in reproductive 
function.  Conversely, exposure to BPA results in apoptosis inhibition in human 
breast cancer cell line MCF-7 for a concentration range of 10 nM – 10 µM (Diel 
et al. 2002) as well in non-malignant epithelial breast cells from high risk donors 
for a concentration of 100 nM (Dairkee et al. 2013). 
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1.4.2 Transcriptional and epigenetic effects 
 
The effect of BPA exposure, in a low-dose concentration range on global gene 
expression profiles was evaluated in distinct cell lines including ER-positive and 
ER-negative Ishikawa endometrial cancer cells (Boehme et al. 2009; Naciff et 
al. 2010), breast cancer cells lines MCF-7 (Buterin et al. 2006), and T47D 
(Buterin et al. 2006) or human peripheral blood cells (PBMCs) (Wens et al. 
2013). In general these studies demonstrate that BPA affects the transcriptional 
pattern of hundreds of genes involved in key cellular processes such as 
proliferation, division and apoptosis in a cell type and concentration dependent 
manner.  
Furthermore, BPA-induced alterations on transcriptional patterns have been 
correlated to DNA methylation. The epigenetic effect of BPA was first 
demonstrated in mice after maternal exposure to BPA which resulted in 
decreased DNA methylation upstream of the Agouti gene what was prevented 
by maternal dietary supplementation with folic acid (Dolinoy et al. 2007). On 
human primary breast epithelial cells BPA low-dose exposure (4 nM) resulted in 
repressed expression and increased DNA methylation at CpG islands of LAMP3 
(lysosomal-associated membrane protein 3) gene (Weng et al. 2010). Also BPA 
exposure of normal-like human breast epithelial cells (MCF-10F) was shown to 
alter DNA methylation patterns of several genes including those involved in 
apoptosis and DNA repair (Fernandez et al. 2012). Although there is significant 
evidence that BPA is able to influence DNA methylation patterns, the available 
data regarding BPA effects on histone modifications is almost inexistent 
(reviewed in Singh and Li 2012). Still, in human breast cancer cell line MCF-7 it 
was shown that BPA exposure increases the expression of the histone 
methyltransferase EZH2 (enhancer of Zeste Homolog 2) and the overall level of 
histone H3 trimethylation at lysine 27 (H3K27me3) (Doherty et al. 2010).  
 
1.5 BPA interactions  
 
In addition to the direct cellular effects induced by BPA, this chemical is also 
capable to interact with other compounds including natural estrogenic hormones 
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such as E2. In MCF-7 breast cancer cell line combined exposure to BPA at low 
dose and E2 at physiological concentration induces cell proliferation and 
decreases apoptosis (Mlynarcikova et al. 2013). Also in colon cancer cell line 
DLD-1 E2 pro-apoptotic action is antagonized by BPA through inhibition of 
cascade 3 activation (Bolli et al. 2010). Interestingly, it was also shown that BPA 
at environmental relevant dosages (0.01 – 10 nM) is as effective as E2 in 
antagonizing cytotoxicity of the chemotherapeutic agent cisplantin in breast 
cancer cells T47D and MDA-MB-468 (LaPensee et al. 2010). Moreover, in the 
same cells lines low BPA concentrations (0.1-10 nM) were also reported to 
antagonize the cytotoxicity of vinblastine and doxorubicin (DOX), also 
commonly used in cancer chemotherapy. Relevantly, in the case of BPA/DOX 
interaction the same study demonstrated that the BPA antagonistic effects were 
independent from classical estrogen receptors and potentially associated with 
increased expression of antiapoptotic proteins (LaPensee et al. 2009).  
BPA interactions with plant-derived compounds have also been demonstrated. 
A few studies have suggested that some plants extracts may effectively 
antagonize BPA induced cytotoxicity. In hepatoma cells HepG2 two distinct 
medicinal plant combinations were able to antagonize the cytotoxicity of a 
Bisphenol-A/Atrazine mixture by restoring cellular viability up to 24-28% 
(Gasnier et al. 2011). In human red blood cells BPA-induced hemolysis was 
decreased by black tea extract or the flavonoid quercetin (Verma and Sangai 
2009). Also genistein, a soy phytoestrogen was reported to efficiently suppress 
BPA ERα mediated proliferation trough inhibition of cell cycle progression in 
ovarian cancer cell line BG-1 (Hwang et al. 2013a).  
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2 Bisphenol A at concentrations found in 
human serum induces aneugenic effects in 
endothelial cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ribeiro-Varandas E, Viegas W, H Sofia Pereira, Delgado M. 2013. Bisphenol 
A at concentrations found in human serum induces aneugenic effects in 
endothelial cells. Mutation Research. 751: 27-33. 
 
 ______________________________________________________________________ 
______________________________________________________________________ 
14 
 
2.1 Abstract 
 
Bisphenol A (BPA) is an endocrine disrupting chemical to which humans are 
exposed. Continuous environmental exposure to BPA leads to its detection in 
the majority of individuals from developed countries with serum concentrations 
ranging from 0.5 to 10 ng/ml in the general population and at much higher 
concentrations associated to occupational exposure. In this work, Umbilical 
Vascular Endothelial Cells (HUVEC) and Human Colon Adenocarcinona (HT29) 
cell lines were utilized to represent endothelial and digestive tract tissues which 
are in direct contact to BPA in vivo. Our results demonstrate that BPA has cell 
type differential effects. Relevantly, BPA concentrations commonly found in 
humans induce micronuclei formation and interfere in cell division processes in 
endothelial cells, resulting in mitotic abnormalities. We also found a BPA 
induced up-regulation of two genes encoding for proteins associated with 
chromosome segregation, namely borealin/cell division cycle A8 (CDCA8) and 
shugoshin-like2 (SGOL2). Taken together, the aneugenic effects observed in 
endothelial cells (HUVEC) substantiate increasing concerns of BPA exposure in 
levels currently detected in humans.  
 
2.2 Introduction 
 
Endocrine disrupting chemicals (EDCs) are exogenous agents that have the 
capacity to behave as biological signals and interfere with/or mimic estrogenic 
hormones. Exposure to these compounds can therefore simultaneously and 
differentially trigger specific signaling pathways responsible for the nature and 
magnitude of biological responses in diverse cell types (Shanle and Xu 2010). 
Bisphenol A (BPA) is a widely utilized EDC, employed in the manufacture of a 
variety of consumer products such as polycarbonate plastic and resins, medical 
tubing, toys, water pipes, and dental sealants. BPA has been detected in 
biological tissues and fluids of the majority of individuals in developed countries, 
including amniotic fluid, placenta, urine and blood. A recent extensive revision 
on BPA detection in humans indicates levels of internal exposure ranging from 
0.5–10 ng/ml (Vandenberg et al. 2010).  
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Tissue specific as well as developmentally related BPA induced alterations are 
thought to be mediated by nuclear and/or non-nuclear estrogen receptors, 
which in turn are involved in various cell-signaling pathways (Welshons et al. 
2006; Wetherill et al. 2007). BPA promotion of cell proliferation has been 
associated with nuclear estrogen receptor alpha (ERα) in distinct human cell 
lines (LaPensee et al. 2009; Ptak et al. 2011; Ricupito et al. 2009). On the other 
hand, the transmembrane estrogen receptor (GPR30) that holds much higher 
affinity for BPA than nuclear ER has been implicated in low dose response 
(Shanle and Xu 2010; Thomas and Dong 2006). BPA induced cell proliferation 
has been related with activation of PKA and PKG pathways via GPR30 
(Bouskine et al. 2009). In a recent publication, it was also shown that BPA can 
induce Erk1/2/c-fos signaling through GPR30 (Dong et al. 2010).  
Significantly, BPA has been characterized as an aneugenic chemical (Parry et 
al. 2002), and it has been suggested it directly interferes with the mechanisms 
of cell division (George et al. 2008). BPA induced effects include aberrations in 
spindle morphology, congression of chromosomes malfunctions at metaphase, 
nondisjunction at anaphase and abnormal microtubule organization in both 
cultured somatic cells and oocytes (Can et al. 2005; Lenie et al. 2008; 
Nakagomi et al. 2001; Pacchierotti et al. 2008; Parry et al. 2002). Furthermore, 
the expression of genes involved in mitotic processes also appear to be 
affected by BPA exposure in a variety of cell lines (Bouskine et al. 2009; 
Bredhult et al. 2009; Buterin et al. 2006; Naciff et al. 2010). 
The aim of the present work was to investigate potential aneugenic effects of 
low concentration BPA exposure in two human cell types, Human Umbilical 
Vascular Endothelial Cells (HUVEC) and Human Colon Adenocarcinona cell 
line (HT29). HUVEC are primary vascular endothelial cells, and therefore 
models of cells that are in permanent contact with BPA in vivo. On the other 
hand, HT29 originated from the digestive tract, which is also directly exposed to 
BPA since exposure in humans is generally by ingestion (Vandenberg et al. 
2007). The BPA concentrations used were 10 ng/ml, that is within the range 
detected in human blood for environmental exposure (Vandenberg et al. 2010),  
and 1 µg/ml within the range detected for occupational exposure (He et al. 
2009; Li et al. 2010). Cytotoxic and genotoxic effects of BPA were evaluated 
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through analysis of cell viability, DNA integrity and micronuclei induction. 
Furthermore we evaluated BPA effects on mRNA levels of specific chromosome 
segregation related genes and performed a cytological analysis of microtubule 
organization and mitotic abnormalities. 
 
2.3 Materials and methods 
 
Cell cultures, reagents and treatments 
HT29 human cell line was purchased from European Collection of Cell Cultures 
(ECACC,UK) and cultivated in 75cm2 flasks with RPMI media containing 
GlutaMAX™ I, 25 mM HEPES (Gibco), supplemented with 10% (v/v) fetal 
bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM L-
glutamine. HUVEC cell line was kindly offered by Dr Ana Costa from Instituto 
Português de Oncologia (IPO), and cultivated in 75cm2 flasks coated with 0.2% 
gelatin. HUVEC were grown in EGM- 2 media (LONZA # CABRCC-3162) 
supplemented with 5% (v/v) fetal bovine serum, 0.2% (v/v) Bovine Brain Extract 
(LONZA #CABRCC-4098), 0.5 ml epidermal growth factor, 0.5 ml R3 insulin-like 
growth factor-1, 2 ml human fibroblast growth factor, 0.5 ml endothelial growth 
factor, 0.5 ml ascorbic acid, 0.2 ml hydrocortisone, 0.5 ml heparin, and 0.5 ml 
gentamicin, for each 500 ml EGM-2. All cell cultures were maintained in a 
humidified 5% (v/v) CO2 atmosphere at 37°C. For treatments and experiments, 
HT29 cells were used between passages 2 and 15 and HUVEC between 
passages 3 and 7 post-confluence. BPA was freshly diluted in ethanol and 
added to the culture media to the final concentration of 10 ng/ml (44 nM) or 1 
µg/ml (4.4 µM). After 24h cultivation, cells were incubated in medium 
supplemented with BPA for 24 h, 48 h or 72 h. BPA is highly stable in solution 
(Kang et al. 2004) and population studies have established that BPA 
concentrations in humans are stable over extended periods of time (Stahlhut et 
al. 2009). For all experiments, negative controls included cells grown in 
standard culture media as well as cells grown in standard culture media 
supplemented with a final concentration of 0.17 mM ethanol corresponding to 
the final concentration of ethanol in BPA treated cultures. BPA treated and 
control cells were analyzed simultaneously for all treatments. 
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Cell viability assay 
Cell viability was evaluated by CellTiter-Blue assay (Promega), which is a 
fluorometric method that assesses cell metabolic capacity. For this, cells were 
plated on 96-well dishes at a density of 3.2 × 104 cells/well. Following overnight 
incubation, cells were treated with BPA at the specific dosages. After 24 h, 48 h 
and 72 h incubation, CellTiter-Blue Solution Reagent was added to each well 
according to manufacturer’s instructions, cells incubated for 4 h and viability 
determined by measuring fluorescent emission at 590 nm using a Synergy HT 
Bio-Tek plate-reader. Experiments were repeated three times with at least three 
replicates per treatment. 
 
Micronuclei analysis  
Cells were cultivated on Petri dishes containing glass coverslips coated with 
0.2% (v/v) gelatin (Sigma). After treatments, cells where fixed with 4% 
paraformaldeyde, DAPI stained and mounted on glass slides with antifade AF1 
(Citifluor) mounting medium for evaluation of micronuclei formation. Images 
were captured using the appropriate excitation and emission filters and 
recorded using an epifluorescence microscope Zeiss Axioskop2 equipped with 
a Zeiss AxioCam MRc5 digital camera. The analysis was performed on results 
of at least two independent experiments with at least two replicates.  
 
TUNEL assay 
For HT29 and HUVEC cell death assessment, cells were plated on Petri dishes 
with 0.2% (v/v) gelatin (Sigma) coated glass coverslips. After BPA treatments, 
cells were fixed in 4% (v/v) paraformaldehyde for 10 min at room temperature 
and subsequently treated with TUNEL assay kit (in Situ Cell Death Detection Kit 
Fluorescein- cat # 11684795910 Roche) according to manufacturers´ 
instructions. Fluorescence images were recorded for each fluorochrome using 
the appropriate excitation and emission filters in an epifluorescence microscope 
Zeiss Axioskop2 equipped with a Zeiss AxioCam MRc5 digital camera. Analysis 
was performed on two independent experiments with two replicates per 
treatment.  
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Immunofluorescence 
Cells were plated on Petri dishes containing glass coverslips coated with 0.2% 
(v/v) gelatin (Sigma). After BPA treatments cells were fixed in 4% (v/v) 
paraformaldehyde for 10 min at room temperature and permeabilized with 
0.25% (v/v) Triton X-100 for 15 min. Fixed cells were then incubated in 5% (w/v) 
BSA/PBS solution for 60 min. For immunodetection cells were incubated 
independently with the primary antidodies anti-acetyl-histone H3 (Lys 56) 
(ab76307, Abcam) or anti- GPR30 (ab39742, Abcam) or simultaneously with 
anti-αTubulin (T9026, Sigma) and anti-λTubilin (T3559, Sigma). Antibodies were 
diluted 1:200 in 1% (w/v) BSA/PBS and incubation was carried out at 37ºC for 
1:30 h. After washing with PBS, conjugated anti-rabbit-FICT IgG (1:200, 
Abcam) or anti-mouse-Cy3 IgG (1:200, Sigma) secondary antibodies were 
added at 1% (w/v) BSA/PBS and incubated for 60 min at 37°C. Cells were then 
washed three times with PBS, and DAPI stained, coverslips were mounted on 
glass slides with antifade AF1 (Citifluor). Immunofluorescence was recorded 
using an epifluorescence microscope Zeiss Axioskop2 equipped with a Zeiss 
AxioCam MRc5 digital camera.  Images were captured for each fluorochrome 
using the appropriate excitation and emission filters and merged with Adobe 
Photoshop 7.0 (Adobe Systems) software. Two replicates for per treatment 
were analyzed for two independent experiments. 
 
Protein extraction and western blotting analysis 
Cells were washed once with PBS and collected by trypsinization and 
centrifugation. For total protein lysate, pellets were resuspended in 500 µl SDS 
buffer (0.125 M Tris-HCL, 10% 2-mercaptoethanol, 2% SDS and 10% Sucrose) 
(Dong et al. 2010) and sonicated on ice 2 x 15 sec 20%. After centrifugation 
(14000 g), the supernatant was transferred to a fresh centrifuge tube and stored 
at -20ºC. Protein concentrations were determined through the Bradford method 
(Protein assay cat. # 500-0006 BioRad). Western blotting electrophoresis on 
polyacrylamide gel were performed as described in (Laemmli 1970) using 50 µg 
of protein samples transferred on to PVDF membranes and stained by Ponceau 
S reagent. The immunoblots were blocked with 3% (w/v) dry milk in PBST 
(0.05% (v/v) Tween 20, 137 mM NaCl, 1.5 mM KH2PO4, 8.1 mM Na2HPO4, 2.7 
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mM KCl) and incubated with primary antibodies: anti-acetyl-histone H3 (Lys 56) 
(ab76307), anti- GPR30 (ab39742), anti-ERb (ab3577) (dilution 1:1000, 1:400, 
1:1500 respectively, Abcam) or anti-αTubulin (T9026) (dilution 1:2000, Sigma)  
Peroxidase-conjugated anti-rabbit (cat # 32460 Pierce Biotechnology) and anti-
mouse (cat # 32430 Pierce Biotechnology)  antibodies were used at dilutions 
1:1250. Detection was performed with SuperSignal West Femto Maximum 
Sensitivity Substrate (cat # 34094 Thermo Scientific) according to the 
manufacturer’s instructions. Immunoreactive protein bands were detected by 
BioRad Chemidoc XRS. Intensity levels of immunoreactive protein bands were 
analyzed by ImageJ software (http://rsbweb.nih.gov/ij/). Two independent 
protein extractions for each treatment were performed and at least three 
western blots were analyzed. 
 
cDNA isolation and real-time quantitative PCR 
Transcriptional analysis of cell division genes CDCA8, SGOL2, Aurora A, γ-
tubulin and the control gene GAPDH was performed by quantitative real-time 
PCR with gene specific primers as listed in table 1. Total RNA was extracted 
from HT29 and HUVEC cells exposed to both concentrations of BPA for 24 h 
and 72 h as well as non-treated and control culture to which ethanol alone was 
added to the culture media. Cells were collected at 80% confluence by 
trypsinization, washed in PBS, centrifuged at 1000 g, and RNA isolated with the 
RNAqueous Kit (Cat  # AM1912 Thermo Scientific) following manufactures´ 
instructions. After verifying concentration and integrity, 3 µg of total RNA was 
utilized for RNase free DNase digestion (RQ1 RNase free DNase, cat #  M6101 
Promega) and first strand cDNA synthesis was completed with random primers 
following manufacturers´ instructions (DYNAmo cDNA syntesis Kit, ca t# F-470L 
Thermo Scientific). The resulting cDNA was utilized for qRT-PCR with the BIO-
RAD SsoFast Eva Green Supermix (BIO-RAD Cat  # 172-5201) utilizing the 
following conditions; 95 °C-3 min, 35 cycles (95 °C-30 sec, 55 °C-30 sec, 72 °C-
40 sec), and 72 °C-5 min. To ensure that genomic DNA was completely absent 
prior to cDNA synthesis, PCRs were performed with 18S primers and 250 ng of 
DNase digested RNA. Control PCRs were also performed for both primer 
combinations without template. Denaturation curves were calculated by 
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measuring single stranded product at 0.5oC intervals from 55oC to 95oC. After 
denaturation curves were observed to ensure correct amplification products, 
threshold cycles (Ct) were equilibrated with mean GAPDH to calculate ∆Ct  (∆Ct  
= Ct of interest – mean GAPDH Ct). Cell cycle associated genes expression 
levels were analyzed by calculating ∆∆Ct (∆∆Ct = ∆Ct a – mean ∆Ct b, where a 
and b are being compared), which in turn was used to determine mean fold 
change (2-∆∆Ct) ± standard deviation between treatments. Experiments were 
repeated three times with at least three replicates per cell treatment/primer 
combination in each experiment. 
 
Table 1 Primers used for qRT-PCR.  
Gene Forward primer (5´→3´) Reverse primer (5´→3´) 
CDCA8 AAGGTAATACAGGTAGATGAA GTTCTCTTCTTGGATGGA 
SGOL2 TACATTCACCTAACATACAA GCTCATCATCACTTACTT 
AURKA GCTGGAGAGCTTAAAATTGCAG TTTTGTAGGTCTCTTGGTATGTG 
γ-Tubulin CTCAAGAGGCTGACGCAGAAT CTGGCTGACATGATGGTAGACAC 
GAPDH GAGTCAACGGATTTGGTCGTA GCAGAGATGATGACCCTTTTG 
a
 GenBank accession numbers (National Center for Biotechnology). 
 
Statistical analysis 
Statistic analysis of was performed comparing cells grown in standard medium 
(control) to cells exposed to vehicle EtOH or BPA using Student’s t Test.  
 
2.4 Results and discussion 
2.4.1 Low BPA concentrations do not affect cell proliferation or viability 
independently of GPR30. 
Potential cytotoxic and genotoxic effects of BPA exposure were evaluated by 
analyzing cell viability and proliferation in HT29 and HUVEC cells using two 
BPA concentrations 10 ng/ml (44 nM) and 1 µg/ml (4.4 µM). The CellTiter-Blue 
assay was utilized to measure viability at three time periods; two corresponding 
to non-confluent cultures (24 h and 48 h) and one where the culture is at 80% 
confluence (72 h) (Figure 1). Our results show no significant differences in 
viability or proliferation associated with BPA exposure. Previous studies have 
demonstrated that high BPA concentrations (equal or greater than 100 µM) are 
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genotoxic, and resulted in decreased cellular proliferation as well as viability 
(Bolli et al. 2008; Kim et al. 2007). However, the literature shows that the effects 
of exposure to low BPA concentrations (in the range of 1 nM to 10 µM) are 
variable. Whereas no detectable effects have been reported in some cell types 
(Bolli et al. 2008; Kim et al. 2007; LaPensee et al. 2009), an increase in cell 
viability and proliferation was observed in others (LaPensee et al. 2009; Ptak et 
al. 2011; Ricupito et al. 2009). This discrepancy in the effects of BPA may be 
dependent on cell type and expression of estrogen receptors, as discussed in 
detail below.  
Positive effects of BPA concentration as low as 1 nM on cell proliferation have 
been described in estrogen receptor alpha (ERα) positive human cell lines 
MCF-7, T47D and OVCAR-3 (LaPensee et al. 2009; Ptak et al. 2011; Ricupito 
et al. 2009). In fact, the lack of responsiveness in HeLa and MDA-MB-46 has 
been correlated with the absence of this receptor in these human cell lines (Bolli 
et al. 2008; LaPensee et al. 2009). Both HT29 and HUVEC cells used in this 
study express ERβ but not ERα (Campbell-Thompson et al. 2001; Toth et al. 
2008), which could explain the lack of BPA effects on cell proliferation. 
However, increased proliferation was observed in ERβ positive and ERα 
negative cell line JKT-1 when exposed to BPA concentrations ranging from 1 
pM to 10 µM (Bouskine et al. 2009). This study showed that BPA effects in 
JKT1 cells are mediated through a G protein-coupled receptor 30 (GPR30). 
Interestingly, this membrane-bound estrogen receptor has a higher affinity for 
BPA than ERα or ERβ (Thomas and Dong 2006) and has been proposed as a 
mediator of BPA effects at low concentrations (Bouskine et al. 2009; Shanle 
and Xu 2010; Thomas and Dong 2006). In relation to the cells used here, the 
expression of GPR30 had not been analyzed in HT29 and is only expressed in 
HUVEC cultured in specific conditions (Takada et al. 1997). 
Western immunoblotting was utilized to test GPR30 expression in HT29 and 
HUVEC in the culture conditions utilized in this study. The expression of ERβ 
was confirmed for both cell lines as positive controls, evident as a specific 
immunoreactive protein band at 55 kDa (Figure 2A). As expected, GPR30 
expression is not detected in HUVEC (Figure 2A), in agreement with pervious 
results showing that these cells express GPR30 exclusively under stream flow 
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conditions (Takada et al. 1997). Conversely, a clear GPR30 immunoreactive 
protein band with the expected size of approximately 55 kDa is detected in 
HT29 cells (Figure 2A). Immunocytofluorescence shows that GPR30 was 
restricted to the cytoplasm in HT29 cells (Figure 2B), with identical distribution 
to that previously observed in MDA-MB231 and HEC50 cells and characteristic 
of its endoplasmic reticulum association (Otto et al. 2008). To the best of our 
knowledge, this is the first time that the expression of GPR30 is demonstrated 
in this cell line. More importantly, the presence of GPR30
 
does not result in a 
positive response in cell proliferation in HT29 cells, in contrast with the results 
obtained in JKT-1 cells (Bouskine et al. 2009). This indicates that although 
GPR30 may have a role in mediating the responses to BPA exposure in some 
cell types, its expression does not result in induced cell proliferation in all 
GPR30 positive cells.  
 
 
 
 
 
 
Figure 1 -  BPA does not affect cell viability. Viability assay of HUVEC (A) and HT29 
(B) cells after 24 h, 48 h and 72 h culture in control (control medium), vehicle (control 
media supplemented with 0.17 mM ethanol) and 10 ng/ml or 1 µg/ml of BPA. 
Cultivation and viability assays were performed simultaneously for all growth 
conditions. Results are presented as mean ± standard deviation for fluorescence 
intensity at 590 nm (using 560 nm for excitation). 
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Figure 2 - GPR30 is present in HT29 cell line. (A) Western immunoblot confirmed the 
presence of Estrogen Receptor beta (ERβ) in both HUVEC and HT29 cell lines (upper 
panel). GPR30 receptor is detected in HT29 cells but not in HUVEC (lower panel). The 
detection of both estrogen receptors where performed on the same PVDF membrane. 
(B) Immunocytofluorescence images of representative interphase HT29 cells showing 
GPR30 distribution signals (left) and corresponding DNA DAPI staining (right), bar = 5 
µm.  
 
2.4.2 Low BPA concentrations induce micronuclei formation without 
affecting DNA integrity. 
Potential cytotoxic and genotoxic effects of BPA exposure were evaluated by 
analyzing DNA integrity and micronuclei induction. Effects of BPA exposure on 
DNA stability and damage repair were evaluated through TUNEL assay as well 
as analysis of histone H3 acetylated on lysine 56 (H3K56ac). This post-
translation modification of H3 was recently described to be crucial for genomic 
stability (Yuan et al. 2009), increasing in response to DNA damage and repair 
(Das et al. 2009). The TUNEL assay did not detect DNA double strand breaks 
or apoptotic cells associated to BPA exposure (Figure 3A). There was also no 
detectable variation in nuclear pattern of H3K56ac, where a dispersed 
distribution is observed throughout the nucleus and nucleoli regardless of cell 
line or BPA treatments (Figure 3B). Accordingly, western immunoblotting 
revealed an identical low intensity H3K56ac immunoreactive protein band with 
the expected size of approximately 17 kDa in all conditions tested (Figure 3C). 
These results indicate that the BPA concentrations utilized in this work do not 
affect DNA integrity or the expression of histone H3 acetylated on lysine 56 in 
HUVEC or HT29 cells. 
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Micronucleus (MT) formation occurs due to chromosome segregation errors 
and/or chromosome fragmentation, and is therefore a relevant assay for 
genotoxicity. In this context, we evaluated the frequency of micronucleated cells 
in the distinct growth conditions, as demonstrated in Figure 4. Our results show 
marked differences in sensitivity to BPA between the two cell lines. Although a 
high level of micronucleated cells is observed in HT29 cultured in control 
conditions (4.45%), there is no alteration in the percentage of these cells with 
micronuclei after BPA exposure (4.6% for 10 ng/ml; 4.4% for 1 µg/ml). In 
contrast, micronucleated HUVEC cells are significantly less frequent in control 
conditions (1.1%), but both BPA concentrations resulted in a significant 
increase in the proportion of micronucleated cells (1.6% for 10 ng/ml, t-test, p = 
0.0045; 2.2% for 1 µg/ml, t-test, p = 0.0002) (Figure 4).  
BPA has been described as a genotoxic aneugenic chemical capable of 
inducing aneuploidy and resulting in centromere positive micronuclei (Kabil et 
al. 2008; Parry et al. 2002; Pfeiffer et al. 1997) in a dose dependent manner. 
However, the concentrations for which effects are detectable vary depending on 
cell type. In human cells lines AHH-1 (Johnson and Parry 2008) and MCL-5 
(Parry et al. 2002) induction of micronuclei was observed only for 
concentrations at least ten times greater than the highest concentration utilized 
in this work, while for MCF-7 cell line a significant increase in the proportion of 
micronucleated cells was observed at a concentration equivalent to the higher 
concentration used here (Kabil et al. 2008). Our results with HT29 and HUVEC 
cell lines support previously described variation in BPA induced micronuclei 
formation between cell types. More importantly, we show for the first time that 
exposure to BPA at low concentrations increase the proportion of micronuclei in 
the HUVEC primary cell line, establishing the potential genotoxic effects of 
exposure to BPA. 
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Figure 3 - BPA does not induce DNA double strand breaks or alter H3K56ac patterns. 
(A) TUNEL assay of HUVEC (left) and HT29 (right) cells. Cells exposed to 1 µg/ml BPA 
show no detectable DNA double strand breaks. Positive controls with DNase treated 
cells are shown on bottom. (B) HUVEC (left) and HT29 (right) cells after 
immunocytofluorescence detection of H3K56ac. 1 µg/ml BPA treated cells (top) show 
H3K56ac interphase pattern identical to control (bottom). Bars = 5 µm. (C) 
Immunoblotting with H3K56ac on HUVEC and HT29 cells grown for 24 h and 72 h in 
control media (C), vehicle (V), 10 ng/ml or 1 µg/ml BPA. An identical histone specific 
band corresponding to approximately 17 kDa is detected in all growth conditions. PVDF 
membranes stained by Ponceau S reagent before immunoblotting of total proteins 
between 40 kDa and 25 kDa of are shown as loading controls.    
 
 
 
  
 
Figure 4 - BPA induces micronuclei in HUVEC cells. Percentage of micronuclei in 
HUVEC and HT29 cells after 72 h of culture in control, vehicle, 10 ng/ml or 1 µg/ml of 
BPA. The results are presented as mean ± standard deviation and total number of cells 
analysed is show in brackets. * a significant difference compared with the treatment 
with vehicle (Student’s t Test, p < 0.005).   
% of micronuclei 
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2.4.3 BPA differentially affects genes related with chromosome 
segregation. 
The expression of genes encoding for proteins involved in chromosome 
segregation was assayed in order to provide more insight into the differential 
effect of low BPA concentrations on micronuclei induction in HUVEC and HT29 
cells. For this purpose, quantitative RealTime-PCR (qRT-PCR) was utilized with 
primers specific for γ-tubulin and Aurora A centrosome components as well as 
two genes involved in chromatid segregation, namely CDCA8 and SGOL2. γ-
tubulin is essential for microtubule polymerization (Raynaud-Messina and 
Merdes 2007) and Aurora A is a mitotic key regulatory protein essential for 
centrosome maturation, spindle organization and chromosome segregation 
(Anand et al. 2003; Kollareddy et al. 2008). CDCA8, also known as borealin/cell 
division cycle A8, is a component of the chromosomal passenger complex 
(CPC) and is one of the master regulators of events involved in mitotic bipolar 
spindle stability (Gassmann et al. 2004). Shugoshin-like2 (SGOL2) is essential 
for accurate chromosome segregation, involved in the regulation of the CPC 
and the phosphorylation of a microtubule depolymerase associated to 
chromosome congression and resolution of improper microtubule attachments. 
In fact SGOL2 depletion induces precocious dissociation of centromeric 
cohesion resulting in separation of sister chromatids (Illingworth et al. 2010; 
Kitajima et al. 2006; Tanno et al. 2010) and is fundamental for the bi-polar 
attachment of chromosomes (Rivera et al. 2012). Comparative gene expression 
values between cells exposed to BPA in vehicle and vehicle alone (mean fold 
change ± standard deviation) show subtle yet significant differences between 
BPA doses, times of exposure and treatments for two of the four genes 
analyzed (Figure 5). Interestingly, the expression of the two genes encoding for 
essential centrosome components (γ-tubulin and Aurora A) do not vary in BPA 
exposed HUVEC cells, in contrast to CDCA8 and SGOL2 genes which encode 
proteins that associate directly with chromosomes.  
qRT-PCR results indicate increased CDCA8 mRNA in HUVEC and HT29 cells 
after exposure to high BPA concentration for 24 h (1.477 ± 0.045 and 1.333 ± 
0.042 for HUVEC and HT29, respectively). After 72 h exposure, this effect is no 
longer observed in HT29 and maintained in HUVEC (1.577 ± 0.112). After 
exposure to low BPA concentrations, CDCA8 expression is altered exclusively 
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in HUVEC cells exposed to BPA for 72 hours (1.304 ± 0.167). Up-regulation of 
SGOL2 is observed solely in HUVEC cells exposed to high BPA concentration 
independent of the exposure time (1.431 ± 0.089 and 1.566 ± 0.116 at 24 h and 
72 h, respectively) (Figure 5A). Our results of BPA induced CDCA8 and SGOL2 
up-regulation diverge from previously published data showing down-regulation 
of these genes in HEECs cultures exposed to 50 µM BPA (Bredhult et al. 2009). 
This may be due to the BPA concentrations assayed, which are much lower 
(ranging 10 and 1000 times lower concentration) in this study and/or to cell type 
specificity. In fact, the present results show that different cell types have distinct 
sensitivities to BPA.  
Our data shows that BPA has more pronounced effects on gene transcription in 
HUVEC than in HT29 cells. Since HT29 expresses GPR30 and in our culture 
conditions HUVEC do not, the observed BPA induced alterations in HUVEC 
cells are independent of the presence of GPR30 receptor. Moreover, we can 
conclude that the observed cell specific effects are not mediated by classical 
nuclear ERs alone, since ERα is not expressed in either cell type and ERβ is 
expressed in both. Taken together, quantitative Real Time PCR data 
establishes that low BPA concentrations (equivalent to those found in human 
serum) can have effects on the expression of genes involved in basic cellular 
processes, such as chromosome segregation. 
 
 
 
Figure 5 - BPA effects on expression of genes involved in chromosome segregation. 
Graphic representation showing quantitative real-time PCR analysis of γ-tubulin, 
AURKA, CDCA8 and SGOL2 gene transcription after exposure to BPA. Fold changes 
(2-∆∆Ct ± standard deviation) in gene expression after 24 h and 72 h of BPA exposure at 
10 ng/ml or 1 µg/ml are shown for (A) HUVEC, and (B) HT29. GAPDH was utilized as a 
reference gene and Student’s t Test significant differences in average mean fold 
changes are shown as **p < 0.01 and *p < 0.05. 
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2.4.4 Low concentrations of BPA disrupt mitotic stability and 
organization in HUVEC. 
It was recently demonstrated that BPA concentrations at least 1000 fold higher 
than the lower dosage used here (10 ng/ml) directly targets tubulin, promoting 
microtubular polymerization and the induction of multiplolar spindles in HeLa 
cells (George et al. 2008). Ectopic poles were found to enclose γ-tubulin but not 
centrin, indicating that disruption of mitotic spindle occurs without centrosome 
amplification (George et al. 2008). Accordingly, it has been previously shown 
that higher concentrations of BPA promote multipolar spindles (George et al. 
2008; Johnson and Parry 2008; Kabil et al. 2008; Ochi 1999; Parry et al. 2002) 
and CREST-positive micronuclei indicating the presence of kinetochores (Kabil 
et al. 2008; Parry et al. 2002; Pfeiffer et al. 1997). Since micronuclei and qRT-
PCR analysis revealed that HUVEC cells are more sensitive to BPA than HT29, 
we performed cytological analysis of BPA induced alterations in cytoskeleton 
organization and γ-tubulin distribution throughout the cell cycle on HUVEC cells.  
Regarding the effects of BPA on the cytoskeleton, γ- and α-tubulin immuno 
labelling patterns in interphase nuclei were identical between control, vehicle 
and BPA treated cells. However, several aberrations were observed associated 
with BPA exposure in mitotic cells, including multipolar spindles with 1 or 2 
ectopic poles that enclose γ-tubulin, microtubule misalignment, and absence of 
midbody structure at telophase cells (Figure 6A). No significant variation was 
found between control and vehicle (t-test, p = 0.1287 for 24 h and t-test, p = 
0.2166 for 72 h, respectively). However significant increases in mitotic 
abnormalities in relation to control were observed for both BPA concentrations, 
particularly evident after 72 h of exposure (24 h: t-test, p = 0.0087 and t-test, p = 
0.0064 for 10 ng/ml and 1 µg/ml respectively; 72 h: t-test, p = 0.0078 and t-test, 
p = 0.0002 for 10 ng/ml and 1 µg/ml respectively) (Figure 6B). Similarly to the 
results of BPA induced micronuclei, the effects on mitotic cells are more severe 
after 72 h of exposure to the higher BPA concentration (Figure 6B). The 
observed spindle irregularities, which have the potential to induce chromosome 
segregation errors and aneuploidy during mitosis, may be responsible for the 
increase in BPA induced micronuclei. This hypothesis is further supported by 
the results of the TUNEL assay as well as analysis of histone H3 acetylated on 
lysine 56 (H3K56ac) indicating lack of evidence of DNA fragmentation. 
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Interestingly, mitotic indexes revealed no differences between BPA treated and 
untreated cells. This is evident as average mitotic indexes of 4.5% at 24 h for all 
treatments, which reduces to approximately 2.5% at 72 h as expected due to 
cell confluence. Although cytostatic assays involving measuring mitotic indexes 
after removing BPA were not performed, our mitotic index and proliferation 
results suggest that these BPA concentrations do not have cytostatic effects on 
HUVEC cells. 
Taken together, our results show that the low BPA concentrations found in 
human samples induce spindle disruption in HUVECs with formation of 
additional γ-tubulin positive poles. As far as we know, this is the first time that 
this is observed after exposure to BPA at such low concentrations. 
 
 
 
 
 
Figure 6 - BPA disrupts mitosis in HUVEC cells. (A) Immunofluorescence results of α-
tubulin (green) and γ-tubulin (red) showing normal metaphase, anaphase and 
telophase cells (top panels). BPA induced mitotic abnormalities of cells in the same 
mitotic stages are shown on bottom panels: multipolar metaphase with four mitotic 
poles positive for γ-tubulin (arrowheads), anaphase with misaligned microtubules 
(bracket) and telophase lacking microtubule midbody structure (arrow). Chromosomes 
are DAPI stained (blue), bar = 5µm. (B) Percentage of mitotic abnormalities after 24 h 
and 72 h culture in control, vehicle, 10 ng/ml or 1 µg/ml BPA. The total number of 
mitotic cell scored is shown in brackets.  
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2.5 Conclusion 
 
The effects of BPA have been extensively studied in recent years, establishing 
that this EDC has diverse effects on human cells that are highly variable 
depending on cell type. In the present study, primary cell line HUVEC is more 
sensitive to BPA than HT29, although both cell types are negative for ERα and 
positive for ERβ and only HT29 expresses GPR30. More importantly, we reveal 
for the first time that exposure to BPA at concentrations currently detected in 
humans are capable of interfering with cell division processes and result in 
mitotic aberrations. Our results confirm increasing concerns that BPA may have 
adverse effects even at extremely low concentrations (Sekizawa 2008; 
Vandenberg et al. 2009; Welshons et al. 2006). Studies such as this are critical 
for BPA risk assessment, especially considering the generalized environmental 
exposure of humans to this EDC.  
 
2.6 References 
 
Anand S, Penrhyn-Lowe S, Venkitaraman AR. 2003. Aurora-a amplification overrides the 
mitotic spindle assembly checkpoint, inducing resistance to taxol. Cancer Cell 3:51-
62. 
Bolli A, Galluzzo P, Ascenzi P, Del Pozzo G, Manco I, Vietri MT, et al. 2008. Laccase 
treatment impairs bisphenol a-induced cancer cell proliferation affecting estrogen 
receptor alpha-dependent rapid signals. IUBMB Life 60:843-852. 
Bouskine A, Nebout M, Brucker-Davis F, Benahmed M, Fenichel P. 2009. Low doses of 
bisphenol a promote human seminoma cell proliferation by activating pka and pkg 
via a membrane g-protein-coupled estrogen receptor. Environ Health Perspect 
117:1053-1058. 
Bredhult C, Sahlin L, Olovsson M. 2009. Gene expression analysis of human endometrial 
endothelial cells exposed to bisphenol a. Reprod Toxicol 28:18-25. 
Buterin T, Koch C, Naegeli H. 2006. Convergent transcriptional profiles induced by 
endogenous estrogen and distinct xenoestrogens in breast cancer cells. 
Carcinogenesis 27:1567-1578. 
Campbell-Thompson M, Lynch IJ, Bhardwaj B. 2001. Expression of estrogen receptor (er) 
subtypes and er beta isoforms in colon cancer. Cancer Research 61:632-640. 
Can A, Semiz O, Cinar O. 2005. Bisphenol-a induces cell cycle delay and alters 
centrosome and spindle microtubular organization in oocytes during meiosis. Mol 
Hum Reprod 11:389-396. 
Das C, Lucia MS, Hansen KC, Tyler JK. 2009. Cbp/p300-mediated acetylation of histone 
h3 on lysine 56. Nature 459:113-U123. 
Dong S, Terasaka S, Kiyama R. 2010. Bisphenol a induces a rapid activation of erk1/2 
through gpr30 in human breast cancer cells. Environ Pollut 159:212-218. 
Gassmann R, Carvalho A, Henzing AJ, Ruchaud S, Hudson DF, Honda R, et al. 2004. 
Borealin: A novel chromosomal passenger required for stability of the bipolar mitotic 
spindle. J Cell Biol 166:179-191. 
 ______________________________________________________________________ 
______________________________________________________________________ 
31 
 
George O, Bryant BK, Chinnasamy R, Corona C, Arterburn JB, Shuster CB. 2008. 
Bisphenol a directly targets tubulin to disrupt spindle organization in embryonic and 
somatic cells. ACS Chem Biol 3:167-179. 
He Y, Miao M, Wu C, Yuan W, Gao E, Zhou Z, et al. 2009. Occupational exposure levels of 
bisphenol a among chinese workers. J Occup Health 51:432-436. 
Illingworth C, Pirmadjid N, Serhal P, Howe K, Fitzharris G. 2010. Mcak regulates 
chromosome alignment but is not necessary for preventing aneuploidy in mouse 
oocyte meiosis i. Development 137:2133-2138. 
Johnson GE, Parry EM. 2008. Mechanistic investigations of low dose exposures to the 
genotoxic compounds bisphenol-a and rotenone. Mutat Res 651:56-63. 
Kabil A, Silva E, Kortenkamp A. 2008. Estrogens and genomic instability in human breast 
cancer cells--involvement of src/raf/erk signaling in micronucleus formation by 
estrogenic chemicals. Carcinogenesis 29:1862-1868. 
Kang JH, Ri N, Kondo F. 2004. Streptomyces sp. Strain isolated from river water has high 
bisphenol a degradability. Lett Appl Microbiol 39:178-180. 
Kastl L, Brown I, Schofield AC. 2009. Effects of decitabine on the expression of selected 
endogenous control genes in human breast cancer cells. Mol Cell Probes 24:87-92. 
Kim K, Son TG, Kim SJ, Kim HS, Kim TS, Han SY, et al. 2007. Suppressive effects of 
bisphenol a on the proliferation of neural progenitor cells. J Toxicol Environ Health 
A 70:1288-1295. 
Kitajima TS, Sakuno T, Ishiguro K, Iemura S, Natsume T, Kawashima SA, et al. 2006. 
Shugoshin collaborates with protein phosphatase 2a to protect cohesin. Nature 
441:46-52. 
Kollareddy M, Dzubak P, Zheleva D, Hajduch M. 2008. Aurora kinases: Structure, functions 
and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc 
Czech Repub 152:27-33. 
Laemmli UK. 1970. Cleavage of structural proteins during assembly of head of 
bacteriophage-t4. Nature 227:680-&. 
LaPensee EW, Tuttle TR, Fox SR, Ben-Jonathan N. 2009. Bisphenol a at low nanomolar 
doses confers chemoresistance in estrogen receptor-alpha-positive and -negative 
breast cancer cells. Environ Health Perspect 117:175-180. 
Lenie S, Cortvrindt R, Eichenlaub-Ritter U, Smitz J. 2008. Continuous exposure to 
bisphenol a during in vitro follicular development induces meiotic abnormalities. 
Mutat Res 651:71-81. 
Li D, Zhou Z, Qing D, He Y, Wu T, Miao M, et al. 2010. Occupational exposure to 
bisphenol-a (bpa) and the risk of self-reported male sexual dysfunction. Hum 
Reprod 25:519-527. 
Loh JK, Lieu AS, Chou CH, Lin FY, Wu CH, Howng SL, et al. 2010. Differential expression 
of centrosomal proteins at different stages of human glioma. BMC Cancer 10:268. 
Naciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW, et al. 2010 
The genomic response of ishikawa cells to bisphenol a exposure is dose- and time-
dependent. Toxicology 270:137-149. 
Nakagomi M, Suzuki E, Usumi K, Saitoh Y, Yoshimura S, Nagao T, et al. 2001. Effects of 
endocrine disrupting chemicals on the microtubule network in chinese hamster v79 
cells in culture and in sertoli cells in rats. Teratog Carcinog Mutagen 21:453-462. 
Ochi T. 1999. Induction of multiple microtubule-organizing centers, multipolar spindles and 
multipolar division in cultured v79 cells exposed to diethylstilbestrol, estradiol-
17beta and bisphenol a. Mutat Res 431:105-121. 
Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, et al. 2008. G protein-
coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by 
estradiol. Endocrinology 149:4846-4856. 
Pacchierotti F, Ranaldi R, Eichenlaub-Ritter U, Attia S, Adler ID. 2008. Evaluation of 
aneugenic effects of bisphenol a in somatic and germ cells of the mouse. Mutat 
Res 651:64-70. 
Parry EM, Parry JM, Corso C, Doherty A, Haddad F, Hermine TF, et al. 2002. Detection 
and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis 
17:509-521. 
 ______________________________________________________________________ 
______________________________________________________________________ 
32 
 
Pfeiffer E, Rosenberg B, Deuschel S, Metzler M. 1997. Interference with microtubules and 
induction of micronuclei in vitro by various bisphenols. Mutat Res 390:21-31. 
Ptak A, Wrobel A, Gregoraszczuk EL. 2011. Effect of bisphenol-a on the expression of 
selected genes involved in cell cycle and apoptosis in the ovcar-3 cell line. Toxicol 
Lett 202:30-35. 
Raynaud-Messina B, Merdes A. 2007. Gamma-tubulin complexes and microtubule 
organization. Curr Opin Cell Biol 19:24-30. 
Ricupito A, Del Pozzo G, Diano N, Grano V, Portaccio M, Marino M, et al. 2009. Effect of 
bisphenol a with or without enzyme treatment on the proliferation and viability of 
mcf-7 cells. Environ Int 35:21-26. 
Rivera T, Ghenoiu C, Rodriguez-Corsino M, Mochida S, Funabiki H, Losada A. 2012. 
Xenopus shugoshin 2 regulates the spindle assembly pathway mediated by the 
chromosomal passenger complex. Embo J 31:1467-1479. 
Sekizawa J. 2008. Low-dose effects of bisphenol a: A serious threat to human health? 
Journal of Toxicological Sciences 33:389-403. 
Shanle EK, Xu W. 2010. Endocrine disrupting chemicals targeting estrogen receptor 
signaling: Identification and mechanisms of action. Chem Res Toxicol 24:6-19. 
Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA. 2004. Differential protein 
profiling in renal-cell carcinoma. Mol Carcinog 40:47-61. 
Stahlhut RW, Welshons WV, Swan SH. 2009. Bisphenol a data in nhanes suggest longer 
than expected half-life, substantial nonfood exposure, or both. Environ Health 
Perspect 117:784-789. 
Takada Y, Kato C, Kondo S, Korenaga R, Ando J. 1997. Cloning of cdnas encoding g 
protein-coupled receptor expressed in human endothelial cells exposed to fluid 
shear stress. Biochem Biophys Res Commun 240:737-741. 
Tanno Y, Kitajima TS, Honda T, Ando Y, Ishiguro K, Watanabe Y. 2010. Phosphorylation of 
mammalian sgo2 by aurora b recruits pp2a and mcak to centromeres. Genes Dev 
24:2169-2179. 
Thomas P, Dong J. 2006. Binding and activation of the seven-transmembrane estrogen 
receptor gpr30 by environmental estrogens: A potential novel mechanism of 
endocrine disruption. J Steroid Biochem Mol Biol 102:175-179. 
Toth B, Saadat G, Geller A, Scholz C, Schulze S, Friese K, et al. 2008. Human umbilical 
vascular endothelial cells express estrogen receptor beta (er beta) and 
progesterone receptor a (pr-a), but not er alpha and pr-b. Histochemistry and Cell 
Biology 130:399-405. 
Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. 2007. Human exposure to 
bisphenol a (bpa). Reproductive Toxicology 24:139-177. 
Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-a and 
the great divide: A review of controversies in the field of endocrine disruption. 
Endocrine Reviews 30:75-95. 
Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder 
G. 2010. Urinary, circulating, and tissue biomonitoring studies indicate widespread 
exposure to bisphenol a. Environ Health Perspect 118:1055-1070. 
Welshons WV, Nagel SC, vom Saal FSV. 2006. Large effects from small exposures. Iii. 
Endocrine mechanisms mediating effects of bisphenol a at levels of human 
exposure. Endocrinology 147:S56-S69. 
Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenscheing C, et al. 
2007. In vitro molecular mechanisms of bisphenol a action. Reproductive 
Toxicology 24:178-198. 
Yuan J, Pu MT, Zhang ZG, Lou ZK. 2009. Histone h3-k56 acetylation is important for 
genomic stability in mammals. Cell Cycle 8:1747-1753. 
 
 ______________________________________________________________________ 
______________________________________________________________________ 
33 
 
3 The Environmental Pollutant Bisphenol A 
Interferes with Nucleolar Structure 
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3.1 Abstract 
 
Bisphenol A (BPA) is an environmental pollutant to which humans are 
universally exposed, evident as low BPA concentrations present in biological 
samples in the majority of individuals in developed countries. Although BPA is 
widely detected in blood, the main source of human exposure is through 
ingestion, as BPA is broadly used in the plastic industry and therefore present in 
food containers. In this work, Umbilical Vascular Endothelial Cells (HUVEC) and 
Human Colon Adenocarcinona (HT29) cell lines were utilized to evaluate the 
effects of low BPA concentrations on nucleolar organization and function. Our 
results show that BPA levels commonly found in humans can affect several 
nucleolar features, including fibrillarin distribution and mean nucleoli number, 
nucleolin gene expression and nucleoli epigenetic marks. 
 
3.2 Introduction 
 
BPA is an extensively utilized industrial Endocrine Disrupting Chemical (EDC) 
with the ability to behave as biological signals and interfere with endogenous 
hormone functions, and is employed in the manufacture of an outstanding 
variety of consumer products (Wetherill et al. 2007).  It has been shown that 
xenobiotics exposure can endorse changes in nucleolus organization and 
protein content in response to signalling pathways activated by the cellular 
stress response (Boulon et al. 2010). However, the effects of BPA on the 
nucleolus is still poorly understood, although anomalies associated to BPA 
exposure including nucleolar fragmentation have been reported in salmon cells 
(Honkanen et al. 2004). Transcription of rRNA genes occurs in the nucleoli 
dense fibrillar component that also comprises fibrilarin and nucleolin proteins, 
two of the most abundant non-ribosomal proteins of the nucleolus (Bartova et 
al. 2010; Mongelard and Bouvet 2007). In this work, we evaluated the effects of 
BPA on fibrillarin organization, 18 rRNA and nucleolin gene transcription as well 
as H3 epigenetic marks associated to gene regulation. Two BPA concentrations 
were assayed, 10 ng/ml, which is within the concentration range found in 
humans (Vandenberg et al. 2010) as well as 1 µg/ml.   
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Two distinct cell lines HUVEC and HT29 cell lines representative of vascular 
and digestive tract tissues which are in direct contact to BPA in vivo were 
utilized (Vandenberg et al. 2007).   
 
3.3 Materials and methods 
 
Cell cultures, reagents and treatments 
HT29 human cell line was cultivated in 75cm2 flasks with RPMI media 
containing GlutaMAX™ I, 25 mM HEPES (Gibco), supplemented with 10% (v/v) 
fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM L-
glutamine. HUVEC cell line was cultivated in 75cm2 flasks coated with 0.2% 
gelatin, grown in EGM-2 media supplemented with BulletKit (Lonza), 5% (v/v) 
fetal bovine serum and 0,2% (v/v) Bovine Brain Extract. Cell cultures were 
maintained in a humidified 5% (v/v) CO2 atmosphere at 37°C. For BPA 
treatments, BPA was freshly diluted in ethanol and added to the culture media 
to final concentrations of 10 ng/ml (44 nM) or 1 µg/ml (4.4 µM). BPA was added 
24 h after cultivation initiation and cells were incubated in BPA supplemented 
medium for an additional 72 h. Cells were also grown in standard culture media 
(control) and standard culture media supplemented with ethanol corresponding 
to the final concentration of ethanol in BPA treated cultures (0.17 mM-vehicle) 
as controls. 
 
Immunofluorescence 
Cells were plated in Petri dishes containing glass coverslips coated with 0.2% 
(v/v) gelatin (Sigma). After treatments, cells were fixed, permeabilized, and 
incubated in 5% (w/v) BSA/PBS solution for 60 min followed by incubation with 
the primary antibodies diluted in 1% (w/v) BSA /PBS. After washing, conjugated 
anti-rabbit-FITC IgG (1:200, Abcam) or anti-mouse-Cy3 IgG (1:200, Sigma) 
secondary antibodies were added and incubated for 60 min at 37°C. Cells were 
then washed, DAPI stained, and coverslips mounted on glass slides with 
antifade AF1 (Citifluor). ImageJ software (http://rsbweb.nih.gov/ij/) was used for 
image analysis, and a minimum of 25 cells per growth condition were analyzed 
for at least two separate experiments.  
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Protein extraction and western blotting analysis 
Cells at 80% confluence were collected by trypsinization, pellets were 
resuspended in 500 µl SDS buffer and sonicated on ice. Protein concentrations 
were determined by the Bradford method. Western blotting electrophoresis on 
polyacrylamide gel was performed as described in (Laemmli 1970) using 50 µg 
total protein samples transferred to PVDF membranes and stained by 
PonceauS reagent. Immunoblots were blocked, incubated with primary 
antibodies, and detected with SuperSignal West Femto Maximum sensitivity 
substrate kit solution. Immunoreactive protein bands are visualized with the 
BioRad Chemidoc XRS.  
 
cDNA isolation and real-time quantitative PCR (qRT-PCR) 
Cells were collected at 80% confluence and RNA isolated with the RNAqueous 
Kit (BioPortugal). After RNase free DNase digestion (RQ1 RNase free DNase) 
cDNA synthesis was performed with random primers using DYNAmo cDNA 
syntesis Kit. cDNA was utilized for qRT-PCR with the BIO-RAD SsoFast Eva 
Green Supermix. The genes analyzed and their respective primer sequences 
are shown in the table 1. Experiments were repeated at least twice with a 
minimum of three replicates per cell treatment/primer combination in each 
experiment. Threshold cycles (Ct ) were equilibrated with GAPDH  to calculate 
∆Ct   (∆Ct  = Ct  gene – mean GAPDH Ct). Gene expression levels were 
analyzed by calculating ∆∆Ct  (∆∆Ct = ∆Ct treatment – mean ∆Ct vehicle), which 
in turn was used to determine mean fold change (2-∆∆Ct) ± standard deviation. 
Table 1. Primers used for qRT-PCR 
Gene Accession nº Forward primer (5´→3´) Reverse primer (5´→3´) 
18S rDNA NR_003286 CATTCGAACGTCTGCCCTAT CCTCCAATGGATCCTCGTTA 
GAPDH  NM_002046 GAGTCAACGGATTTGGTCGTA GCAGAGATGATGACCCTTTTG 
NCL NM_005381 CCTTCTGAGGACATTCCAAGACA ACGGTATTGCCCTTGAAATGTT 
a
 GenBank accession numbers (National Center for Biotechnology). 
 
Statistical analysis 
Cells grown in standard medium (control) were compared to cells exposed to 
vehicle (ethanol) or BPA treatments and mean expression values compared 
with Student’s t Test.  
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3.4 Results  
 
3.4.1 Nucleolar organization is affected by BPA exposure. 
Fibrillarin interphase distribution patterns were evaluated for each growth 
condition by immunofluorescence (Figure 1). No differences were observed 
between control and vehicle, where fibrillarin showed a typical heterogeneous 
nucleolar distribution at interphase (Figure 1A). However on BPA exposed cells, 
there was a significant reduction in signal dispersal observed as an overall 
reduction in the ratios of fibrillarin signal area/nuclear as calculated using 
ImageJ software (Figure 1B). Relative fibrilarin area was reduced in HUVEC 
from 0.102 ± 0.022 in control, to 0.078 ± 0.017 for 10 ng/ml and 0,073 ± 0,02 for 
1 µg/ml BPA treated cells. In HT29, this reduction was from 0.129 ± 0.026 in 
control cells to 0.099 ± 0.023 for 10 ng/ml and 0.136 ± 0.023 for 1 µg/ml BPA 
(Figures 1A and 1B).  HUVEC cells therefore presented a decrease of relative 
fibrillarin area at both BPA concentrations assayed, whereas HT29 cells 
showed a significant decrease of relative fibrillarin area exclusively in cells 
exposed to the lower BPA concentration (Figure 1B). We also observed an 
overall decrease in average number of nucleoli, evident as a significant 
reduction from 4,14 ± 1,08 nucleoli in control HUVEC cells to 3,4 ± 0,95 for 10 
ng/ml and 3,3 ± 0,77 for 1 µg/ml BPA treated HUVEC, and from 2,05 ± 0,7 in 
controls to 1,42 ± 0,49 for 10 ng/ml and 1,33 ± 0,47 for 1 µg/ml BPA treated 
HT29  (Figure 1C). Interestingly, considering that both the overall fibrillarin area 
and number of nucleoli decreased in BPA treatments, no differences were 
found in total fibrillarin content (Figure 1D). 
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Figure 1 - Effects of BPA on fibrillarin in HUVEC and HT29 (A) Interphase nuclei after 
fibrillarin immunodetection (red) in control and after exposure to BPA at 1 µg/ml or at 
10 ng/ml. Merged images with DAPI staining are shown on the right, bar = 5µm. (B) 
Variation in mean number of nucleoli, and (C) variation in relative fibrillarin area. In (B) 
and (C) results are presented as % of variation in relation to control and Student’s t 
Tests significance levels are shown ❖p < 0.05; †p < 0.01 and *p < 0.001 (D) Fibrillarin 
Western blotting revealing an identical band of approximately 40 KDa evident for all 
treatments. Bottom panel shows total protein used as loading controls. 
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3.4.2 BPA effects on nucleolin transcription are cell specific and 
independent of rRNA levels. 
Nucleolin gene (NCL) and 18S rDNA transcription levels were analyzed by qRT-
PCR in HUVEC and HT29 cells (Figure 2). No significant differences were 
observed for 18S rRNA levels independently of cell line or BPA concentration. 
Conversely, a cell specific effect was detected for NCL expression levels, where 
a significant increase of NCL transcripts at both BPA concentrations was 
observed exclusively in HUVEC cells. These results indicate that BPA effects 
on NCL levels depend on cell type and are independent of rRNA levels.    
 
 
 
 
 
 
 
Figure 2 -  Analysis of 18S rDNA and NCL transcript levels by quantitative real-time 
PCR on HUVEC and HT29 cells exposed to BPA at 1 µg/ml or 10 ng/ml. PCR 
threshold cycles (Ct) were equilibrated with GAPDH and results are shown as mean 
fold change (2-∆∆Ct) ± standard deviation in relation to vehicle, *p < 0.001. 
 
3.4.3 Bisphenol A alters H3 epigenetic marks at the nucleolar region. 
Since nucleolar organization is closely associated to several epigenetic factors 
implicated in gene regulation (Bartova et al. 2010) we evaluated BPA effects on 
the distribution histone H3 modified in two distinct lysine residues, namely bi-
methylated lysine 9 (H3K9me2) and tri-methylated lysine 4 (H3K4me3) on 
HUVEC cells (Figure 3A). Although overall nuclear distribution of these 
epigenetic marks were not affected by BPA exposure, decreased levels of 
H3K9me2 accompanied by increased levels of H3K4me3 were observed in the 
nucleolus of  BPA treated cells (Figure 3A, compare top and bottom panels). 
These results were more marked at 1 µg/ml of BPA exposure, suggesting a 
dose dependent effect. Immunoblotting on total protein extracts revealed that 
H3K9me2 and H3K4me3 variation at the nucleoli area is not due to total protein 
levels (Figure 3B), evident as  identical low intensity immunoreactive protein 
bands with the expected size (~17 kDa) for both H3 modifications.  
 
* * 
HUVEC    HT29     HUVEC    HT29 
18S rRNA               NCL 
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Figure 3 - BPA effects on modified histones, H3K9me2 and H3K4me3. (A) HUVEC 
nuclei showing distribution of epigenetic marks H3K9me2 (red) and H3K4me3 (green) 
in controls and cells treated with 1 µg/ml of BPA. Enlargements of the nucleolar region 
are shown in insets. DNA was stained with DAPI (blue) and Merged images are shown 
on the right, bars = 5 µm. (B) Western blotting on total protein extracts result in 
H3K9me2 and H3K4me3 specific bands corresponding to approximately 17 KDa. Total 
protein levels used as loading control are shown.  
 
3.5 Discussion 
 
Toxicological assessment of epigenetic changes is of particular importance, as 
these alternations can have permanent effects on gene expression patterns and 
be passed on transgenerationaly (Crews and McLachlan 2006). Special 
attention has been given to toxic effects of EDCs, such as the estrogenic 
compound BPA, to which human exposure is considered  generalized in 
developed countries (Vandenberg et al. 2009). BPA can simultaneously and 
differentially trigger specific signaling pathways in different cell types, 
responsible for the nature and magnitude of biological responses (Dong et al. 
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2010). The importance of assessing toxicological effects on nucleolar 
organization and epigenetic marks has become exceedingly obvious over the 
last years (Lebaron et al. 2010; Szyf 2007). The nucleolus is one of the main 
targets of signalling pathways activated by the cellular stress response 
(Magakian et al. 2009), however the existent  information regarding BPA effects  
on nucleolar organization and function is still extremely scarce. In this work, we 
show that BPA has a number of effects on the nucleolus, a nuclear 
compartment involved in numerous essential cellular processes. 
Immunocytofluorescence with the nucleolar marker fibrillarin shows that BPA 
exposure results in a reduction of active nucleolar regions in both studied cell 
lines. This indicates that BPA is capable of nucleolar disruption and interfering 
with mechanisms of nucleolar architecture and organization. It should be 
emphasized that these effects were also observed in cells exposed to the lower 
BPA concentration used in this work (10 ng/ml), which it is within the range of 
BPA levels found in humans as a result of common environmental exposure 
(Vandenberg et al. 2010). We observe a decrease in the relative area of 
fibrillarin in HUVEC cells for both BPA treatments assayed, while this effect was 
only observed in HT29 cells exposed to the lowest BPA concentration. This not 
only reveals that BPA has differential effects on distinct cells, but more 
importantly, demonstrates that extremely low BPA dosages can trigger 
alterations that are not detected in higher dosages. In addition, BPA induces up-
regulation of nucleolin mRNA levels exclusively on HUVEC cells independently 
of rDNA transcription. Like fibrillarin, nucleolin is an integral protein of the dense 
fibrillar nucleolar component involved in several major cellular functions 
(Bartova et al. 2010). Finally, BPA induces alterations on epigenetic marks 
H3K9me2 and H3K4me3, associated respectively to transcriptional silencing 
and transcriptional competence (Bartova et al. 2010). The observed decreased 
nucleolar H3K9me2 and increased nucleolar H3K4me3 levels suggest that BPA 
induces a more a permissive transcriptional environment in the nucleolus. In 
accordance, decreased H3K9me2 nucleolar levels have been observed in cells 
exposed to the DNA hypomethylation agent 5-azacytitine (Bartova et al. 2010) 
and BPA has been shown to induce DNA hypomethylation in animals (Bromer 
et al. 2010; Dolinoy et al. 2007). This suggests that the observed changes in 
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nucleolar epigenetic marks might be mediated by a reduction in the methylation 
status of nucleolar associated chromatin. Taken together, our results showing 
numerous effects of BPA on nucleolar structure support the increasing concern 
regarding BPA risk assessment (reviewed in Vandenberg et al., 2009). 
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4.1 Abstract 
 
Bisphenol A (BPA) is a widely utilized endocrine disruptor capable of mimicking 
endogenous hormones, employed in the manufacture of numerous consumer 
products, thereby interfering with physiological cellular functions. Recent 
research has shown that BPA alters epigenetic cellular mechanisms in 
mammals and may be correlated to enhanced cellular senescence. Here, the 
effects of BPA at 10 ng/mL and 1 µg/mL, concentrations found in human 
samples, were analyzed on HT29 human colon adenocarcinona cell line and 
Human Umbilical Vein Endothelial Cells (HUVEC). Quantitative Real-Time 
Polymerase Chain Reaction (qRT-PCR) transcriptional analysis of the Long 
Interspersed Element-1 (LINE-1) retroelement showed that BPA induces global 
transcription deregulation in both cell lines, although with more pronounced 
effects in HUVEC cells. Whereas there was an increase in global transcription 
in HT29 exclusively after 24 h of exposure, this chemical had prolonged effects 
on HUVEC. Immunoblotting revealed that this was not accompanied by 
alterations in the overall content of H3K9me2 and H3K4me3 epigenetic marks. 
Importantly, cell viability assays and transcriptional analysis indicated that 
prolonged BPA exposure affects aging processes in senescent HUVEC. To our 
knowledge this is the first report that BPA interferes with senescence in primary 
vascular endothelial cells, therefore, suggesting its association to the etiology of 
age-related human pathologies, such as atherosclerosis. 
 
4.2 Introduction 
 
Bisphenol A (BPA) is an industrial chemical, employed in the manufacture of 
many consumer products such as polycarbonate plastics and epoxy resins. The 
main source of human exposure to BPA is due to leaching from containers 
resulting in its ingestion (Ballesteros-Gomez et al. 2009; Mezcua et al. 2012). 
Biomonitoring studies have showed that environmental exposure results in 
detectable internal BPA levels in the majority of individuals analyzed, (reviewed 
in Vandenberg et al. 2010) and particularly high levels associated with 
occupational exposure (He et al. 2009; Li et al. 2010). BPA is an environmental 
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xenoestrogen capable of triggering distinct estrogen-signalling pathways with 
potential consequences for human health, (reviewed in Rubin 2011). Several 
studies show that BPA at very low concentrations alters proliferation kinetics 
and expression of cell cycle related genes, (Ptak et al. 2011; Ribeiro-Varandas 
et al. 2013). Moreover, BPA exposure can affect DNA methylation and 
consequently gene expression, (reviewed in Singh and Li 2012). This was first 
observed in mice where BPA induced hypomethylation of the intracisternal A 
particle (IAP) retrotransposon results in altered expression of associated genes 
(Dolinoy et al. 2007). Furthermore genome wide analysis of DNA methylation in 
the developing mouse forebrain revealed that 64% of the loci analyzed had 
developmental stage-dependent hyper or hypo methylation alterations 
associated with BPA exposure (Yaoi et al. 2008). Altered transcription patterns 
associated with modifications in DNA methylation have also been reported for 
several genes in human cells exposed to BPA (Fernandez et al. 2012). 
Although there is substantial evidence that BPA affects DNA methylation, the 
effects of this chemical on histone modifications remain largely unknown, 
(reviewed in Singh and Li 2012). One report revealed that increased expression 
of the histone methyltransferase enhancer of Zeste Homolog 2 (EZH2) is 
induced by BPA with consequent increase in the overall level of histone H3 
trimethylation at lysine 27 (H3K27me3), both in human breast cancer cells and 
in mouse mammary glands (Doherty et al. 2010). Recently, we have also shown 
that BPA alters intranucleolar distribution of two distinct H3 post-translation 
modifications (H3K4me3 and H3K9me2) in primary human endothelial cells 
(HUVEC), although without alteration in the global level of these two epigenetic 
marks (Ribeiro-Varandas E. 2012).  
Numerous studies have established a close relationship between epigenetics 
and aging. Epigenetic modifications have been highly correlated with age-
related pathologies such as cancer, neurodegenerative and cardiovascular 
disorders, as wells as physiological processes of aging itself, (reviewed in Boyd-
Kirkup et al. 2013; D'Aquila et al. 2013). Cellular aging is characterized by 
continuous physiological alterations and loss of replicative capacity. In primary 
cell culture, after a number of population doublings in cell cultures, actively 
dividing cell numbers decrease as cells enter replicative senescence. 
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Senescence can also be induced by exposure to subcytotoxic doses of stressful 
agents such as oxidants or ethanol (Dumont et al. 2002; Toussaint et al. 2000). 
Accordingly, it has been recently shown that BPA may have an important role in 
enhanced cellular senescence in normal human mammary epithelial cells 
(HMEC), attributable to deregulation of cell cycle regulatory genes (Qin et al. 
2012). A relevant fact is that high urinary BPA concentrations have been 
correlated with pathogenesis of age-related diseases such as coronary and 
carotid atherosclerosis (Lind and Lind 2011; Melzer et al. 2010; Melzer et al. 
2012), a form of accelerated arterial senescence (Andreassi 2008). However, 
despite the extensive research on BPA effects in human cancer cells, effects of 
continuous contact on vascular primary cells are mostly unknown.  
In this work, we utilized HUVEC and HT29 human colon adenocarcinona cell 
line to compare BPA effects on primary cells of vascular tissue and cancer cells 
from digestive tract tissue. The Long Interspersed Element-1 (LINE-1 or L1) is a 
highly abundant retroelement distributed throughout the human genome. To 
access BPA effects on HT29 and HUVEC cells global transcription, we 
evaluated the expression of two distinct regions of LINE-1 (Aporntewan et al. 
2011). In addition, BPA effects on cellular viability and expression of 
senescence associated genes were analyzed on aging HUVEC cells.  
 
4.3 Materials and methods 
  
Cell cultures and reagents 
The effects of BPA were analyzed on HT29 and HUVEC representative of 
digestive and vascular tract tissues, respectively, which are exposed to BPA in 
vivo. HT29 human colon adenocarcinoma cell line was purchased from the 
European Collection of Cell Cultures (ECACC, London, UK) and was cultivated 
in 75 cm2 flasks with RPMI media containing GlutaMAX™ (#61870010, 
Invitrogen, Carlsbad, CA, USA), supplemented with 10% (w/v) fetal bovine 
serum (#16000-044, Invitrogen), 100 U/mL penicillin, 100 mg/mL streptomycin 
and 2 mM L-glutamine. Primary vascular endothelial (HUVEC) cells were kindly 
provided by Neo-vascularization Lab (IMM, Lisbon, Portugal), and cultivated in 75 
cm2 flasks coated with 0.2% (w/v) gelatin. HUVEC were grown in EGM-2 media 
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supplemented with the respective specific BulletKit (#CC-3156 and #CC-4176, 
LONZA, Basel, Switzerland) and with 5% (v/v) fetal bovine serum and 0.2% 
(w/v) Bovine Brain Extract (#CC-4098, LONZA). All cell cultures were 
maintained in a humidified 5% (v/v) CO2 in air atmosphere at 37 °C. For 
treatments and experiments, HUVEC were used between passages 3–6 (young 
HUVEC) and passages 11–19 (aging HUVEC). For aging cell passages were 
performed every 3–4 days independently of the confluence status and seeded 
at an identical density (3.2 × 103 cel/cm2) for all conditions assayed. 
 
 BPA treatments and controls 
After subculture procedure cells were stabilized for 24 h in standard growth 
medium before all experiments. BPA was freshly diluted in ethanol and added 
to the culture media to final concentrations of 10 ng/mL (44 nM) or 1 µg/mL (4.4 
µM). As negative controls cells were grown in either standard culture media or 
in media supplemented with ethanol (vehicle) at a final concentration of 0.17 
mM, corresponding to the vehicle added for both BPA concentrations assayed. 
For short exposure treatments, HT29, young (passages 4 and 6) and aging 
(passages 12) HUVEC were incubated in medium with BPA or control media for 
24 or 72 h. For long and continuous BPA exposure, HUVEC were maintained in 
medium with or without BPA from passage 12 to passage 19. At each passage, 
cells were collected by trypsinization and cellular viability evaluated with trypan 
blue. 
 
cDNA isolation and real-time quantitative PCR 
Transcriptional analysis was performed by qRT-PCR for two distinct regions of 
the LINE1 retrolement (L1-3' and L1-5') and for osteonectin (SPARC), 
fibronectin (FN1), p21, FOS, bcl-xL, NCL and 18S rRNA genes as well as 
control genes encoding GAPDH and β-actin, using the specific primers listed in 
Table 1.Total RNA was extracted from trypsinized cells with the RNAqueous Kit 
(#AM1912, Invitrogen) following manufacturers’ instructions. After verifying 
concentration and integrity, 3 µg of total RNA was utilized for RNase free 
DNase digestion (RQ1 RNase free DNase, #M6101, Promega, Madison, WI, 
USA) and first strand cDNA synthesis was completed with random primers 
 ______________________________________________________________________ 
______________________________________________________________________ 
48 
 
(DYNAmo cDNA syntesis Kit, #F-470L, Thermo Scientific, Waltham, MA, USA). 
The resulting cDNA was utilized for qRT-PCR with SsoFast Eva Green 
Supermix (#172-5201, BioRad, Hercules, CA, USA) utilizing the following 
conditions; 95 °C–3 min, 35 cycles (95 °C–30 s, 55 °C–30 s), 72 °C–5 min 40 
°C. To ensure that genomic DNA was completely absent prior to cDNA 
synthesis, PCRs were performed with 18S primers and 250 ng of DNase 
digested RNA. Control PCRs were also performed for both primer combinations 
without template. Transcriptional analysis experiments were repeated at least 
three times and in each experiment at least three technical replicates per cell 
treatment/primer combination were performed. All comparisons of expression 
levels were performed on identical cDNA dilutions. After denaturation curves 
were observed to ensure correct amplification products, threshold cycles (Ct) 
were equilibrated with mean GAPDH and β-actin to calculate ∆Ct (∆Ct = Ct of 
interest – mean (GAPDH-β-actin) Ct) since no significant differences were 
detected between the two reference genes. Gene expression levels were 
analyzed by calculating ∆∆Ct (∆∆Ct = ∆Ct a – mean ∆Ct b, where medium a 
and b are being compared). Results are presented as log2 of the mean fold 
change (2−∆∆Ct) ± standard deviation. Student’s t test was used for statistical 
analysis. 
 
Table 1 Primers used for qRT-PCR.  
Gene Accession nº Forward primer (5´→3´) Reverse primer (5´→3´) 
L1-5´  M80340.1 GGCCAGTGTGTGTGCGCACCG CCAGGTGTGGGATATAGTCTCGTGG 
L1- 3´  M80340.1 CAGGAAGGGGAATATCACACTC TGCGCTGCACCCACTAACTC 
SPARC NM_003118 CTGTGGGAGCTAATCCTG GGGTGCTGGTCCAGCTGG 
FN1 NM_002026 TGTGGTTGCCTTGCACGAT GCTTGTGGGTGTGACCTGAGT 
p21 NM_000389 CTGGAGACTCTCAGGGTCGAA CCAGGACTGCAGGCTTCCT 
FOS NM_005252 AGGAGAATCCGAAGGGAAAG  CAAGGGAAGCCACAGACATC  
bcl-xL NM_001191 TTACCTGAATGACCACCTA ATTTCCGACTGAAGAGTGA 
NCL NM_005381 CCTTCTGAGGACATTCCAAGACA ACGGTATTGCCCTTGAAATGTT 
18SrRNA NR_003286 CATTCGAACGTCTGCCCTAT CCTCCAATGGATCCTCGTTA 
GAPDH NM_002046 GAGTCAACGGATTTGGTCGTA GCAGAGATGATGACCCTTTTG 
β-actin NM_001101 GGTCATCTTCTCGCGGTTGGCCTTGGGGT CCCCAGGCACCAGGGCGTGAT 
a
 GenBank accession numbers (National Center for Biotechnology). 
 
 
Protein extraction and western blotting analysis 
For total protein lysate, cell pellets of trypsinized cultures were resuspended in 
500 µL SDS buffer (0.125 M Tris–HCl, 10% (v/v) 2-mercaptoethanol, 2% (w/v) 
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SDS and 10% (w/v) sucrose) (Dong et al. 2011) and sonicated on ice 2 x 15 s. 
After centrifugation (14000 g), the supernatant was transferred to a fresh 
centrifuge tube and stored at −20 °C. Protein concentration was determined by 
the Bradford method (Protein assay, #500-0006, BioRad) and electrophoresis 
on polyacrylamide gels was performed using 50 µg of protein samples, 
transferred onto polyvinylidene difluoride membranes (PVDF) membranes, and 
stained by PonceauS reagent. The immunoblots were blocked with 3% (w/v) dry 
milk in PBST (0.05% (v/v) Tween 20, 137 mM NaCl, 1.5 mM KH2PO4, 8.1 mM 
Na2HPO4, 2.7 mM KCl) and incubated with primary antibodies: anti-trimethyl-
histone H3 (Lys 4) (#ab8580, dilution 1:500; Abcam, London, UK) or anti-
dimethyl-histone H3 (Lys 9) (#ab1220, dilution 1:2000; Abcam), and anti-α-
tubulin (#T9026, dilution 1:2000; Sigma-Aldrich, St. Louis, MO, US). Secondary 
peroxidase-conjugated anti-rabbit and anti-mouse antibodies (#32460 and 
#32430, respectively; Pierce Biotechnology, Rockford, IL, USA) were used 
(dilutions 1:1250). Detection was performed with SuperSignal West Femto 
Maximum sensitivity substrate kit (#34096, Thermo Scientific) and  
BioRad Chemidoc XRS. Two independent protein extractions for each 
treatment were performed and Western blots repeated for reproducibility. 
 
Cell viability assay 
Cell viability assessment was performed on 96-well dishes using CellTiter-Blue 
Viability Assay (#G8081, Promega) according to manufacturer’s instructions. 
After 4 h incubation fluorescence emission at 590 nm was measured using 
BioTek microplate reader Synergy HT. Cultivation and viability assay was 
performed simultaneously for all growth conditions. Statistic analysis was 
performed comparing treated cells with cells grown in standard medium. At 
least three independent experiments were performed with three replicates each 
per treatment. Student’s t test was used for statistical analysis. 
 
Immunofluorescence 
Cells were grown over glass coverslips coated with 0.2% (w/v) gelatin. After 
treatments, cells were fixed in 4% (v/v) paraformaldehyde for 10 min at room 
temperature and permeabilized with 0.25% (v/v) Triton X-100 for 15 min. Fixed 
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cells were then incubated in 5% (w/v) BSA/PBS solution for 60 min and then 
incubated overnight at 4 °C with α-tubulin primary antibody (# ab7291, Abcam) 
diluted 1:200 in 1% (w/v) BSA/PBS. Detection was performed with conjugated 
anti-mouse-Cy3 IgG (#C2181, Sigma-Aldrich) secondary antibody diluted 1:200 
in 1% (w/v) BSA/PBS for 60 min at 37 °C. Cells were then DAPI stained, and 
coverslips mounted on glass slides with antifade AF1 (Citifluor, London, UK). 
Immunofluorescence images were recorded with epifluorescence microscope 
Axioskop2 (Carl Zeiss, Oberkochen, Germany) equipped with a AxioCam MRc5 
(Carl Zeiss) digital camera and superimposed with Adobe Photoshop 7.0 
(Adobe Systems, San Jose, CA, USA) software. 
  
4.4 Results and Discussion 
 
4.4.1 Bisphenol A (BPA) Alters Global Transcription in HT29 Human 
Colon Adenocarcinona Cell Line and Human Umbilical Vein Endothelial 
Cells (HUVEC). 
Considering that the main route of BPA exposure in humans occurs via 
ingestion followed by entrance into blood circulation, HT29 cell line and HUVEC 
were utilized as representatives of digestive tract and vascular tissues, 
respectively. BPA is extensively metabolized leading to biological inactivation, 
however, low levels of free BPA, the bioactive form, are found in human tissues 
and fluids (Vandenberg et al. 2010). Two distinct physiological relevant 
concentrations of free BPA were assayed, 10 ng/mL within the range found in 
human samples due to environmental exposure (Melzer et al. 2010; 
Vandenberg et al. 2010) and 1 µg/ml associated to occupational exposure (He 
et al. 2009; Li et al. 2010). BPA is known to affect the transcriptional expression 
of several genes involved in major cellular processes in different cell lines 
(Boehme et al. 2009; Bredhult et al. 2009; Buterin et al. 2006; Naciff et al. 
2010). In order to assess the BPA effects on general transcription, the relative 
transcription of two sequences from the 5' and 3' regions of LINE-1 was 
evaluated. LINE-1 is a ~6 kb non-site-specific autonomous, non-Long Terminal 
Repeat retrotransposon that comprises approximately 17% of the human 
genome (Ostertag and Kazazian 2001) with more than 2500 L1 copies located 
in over 1400 genes (Aporntewan et al. 2011).  
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Quantitative RealTime-PCR (qRT-PCR) was performed with two sets of L1 
specific primers (L1-5` and L1-3`) previously utilized for the evaluation of 
epigenetic gene regulatory mechanisms in cancer cells (Aporntewan et al. 
2011). Transcriptional levels were compared between BPA and vehicle (mean 
log2 fold change ± standard deviation) in young HUVEC cells (passage 4, p4) 
as well as in the immortal cell line HT29 after 24 and 72 h treatments (Figure 
1A, B). L1 transcription levels were significantly altered in HUVEC cells for both 
exposure times, however the early response (24 h) showed to be dose 
dependent with both sequences being up-regulated for the higher BPA 
concentration (1 µg/mL) (0.295 ± 0.165 for L1-5' and 0.55 ± 0.159 for L1-3'). 
Interestingly, after 72 h exposure, there was a significant decrease in the 
expression levels of L1-5' for 10 ng/mL BPA (−0.528 ± 0.279) and in both 
sequences for BPA at 1 µg/mL (−0.294 ± 0.14 for L1-5' and −1.176 ± 0.77 for 
L1-3') (Figure 1A). These results reveal that BPA affects 5' and 3' L1 sequences 
differentially in a dose dependent manner, particularly for the longer exposure 
time (72 h). Contrary to HUVEC, in HT29 cells L1 transcription was significantly 
increased exclusively after 24 h BPA exposure, at the lower BPA concentration 
assayed (0.315 ± 0.144 in L1-5' and 0.702 ± 0.479 in L1-3' for 10 ng/mL BPA). 
There were no effects in L1 transcription on HT29 cells exposed to BPA for 72 h 
(Figure 1B), suggesting that the HT29 response to BPA is lost with prolonged 
exposure. 
Furthermore, there is evidence that BPA exposure affects DNA methylation of 
various genes (Fernandez et al. 2012) as well as retroelement sequences 
(Dolinoy et al. 2007). However information regarding BPA effects on histone 
modifications is almost inexistent (Singh and Li 2012). Here, we analyzed BPA 
effects on global content of two H3 histone modifications (H3K4me3 and 
H3K9me2) in HT29 cells. H3K4me3 and H3K9me2 are generally associated to 
gene activation and silencing, respectively (Hon et al. 2009). Immunoblotting of 
total protein extracts utilizing antibodies specific for each H3 modification 
revealed immunoreactive protein bands with the expected size of approximately 
17 kDa (Figure 1C). No differences in the global content of modified histones 
were detected between BPA treatments and controls, as we have previously 
shown for HUVEC cells (Ribeiro-Varandas E. 2012). However, BPA induced 
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modifications of these epigenetic marks at particular genes cannot be excluded. 
Previous results have shown that BPA increases expression of histone methyl 
transferase EZH2 resulting in increased trimethylation of H3K27 (H3K27me3), a 
modification associated with transcriptional repression (Doherty et al. 2010). 
Considering that H3K4 and H3K9 methylation is independent of EZH2 (Varier 
and Timmers 2011), our results suggest that BPA differentially affects distinct 
histone methylation pathways.  
L1 transcription analysis revealed that young primary HUVEC are more 
sensitive to BPA than HT29 cancer cells, in accordance with our previous 
results regarding BPA micronuclei induction and transcription alteration of 
chromosome segregation related genes (Ribeiro-Varandas et al. 2013). The 
less pronounced response to BPA in HT29 is not related with lack of expression 
of estrogen receptors, since both HUVEC and HT29 cells express classical 
estrogen receptor beta and HT29 expresses also the G protein-coupled 
estrogen receptor 1 (GPER) (Ribeiro-Varandas et al. 2013). It is important to 
notice that BPA affinity is considerably higher for GPER than for the classical 
ERs and recent studies have implicated this signaling pathway in BPA cellular 
response (Dong et al. 2011; Pupo et al. 2012). The lower responsiveness of 
HT29 may therefore be related with intrinsic features of cancer cells that render 
them more insensitive to external signals (Hanahan and Weinberg 2011). Given 
the higher BPA sensitivity of HUVEC and the fact that these are primary cells 
that undergo senescence in culture, BPA effects on L1 transcription in HUVEC 
at passage 12 (p12), i.e., senescent cells were also analyzed(Khaidakov et al. 
2011). Opposite BPA effects were detected for both L1 sequences with a 
decrease in L1-5' (−0.377 ± 0.221) and an increase in L1-3' transcriptional 
levels (0.722 ± 0.423) on aging HUVEC (Figure 1D), suggesting that this 
chemical may induce epigenetic modifications unevenly throughout the 
genome. Furthermore, these results show that the effects of BPA on L1 
transcription differ depending on culture time, with aging cells having a 
pronounced response. 
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Figure 1 - Analysis of BPA effects on L1 transcription levels and H3K9me2 and 
H3K4me3 epigenetic marks. (A, B) L1-5' and L1-3' transcriptional analysis on young 
(passage 4, p4) Human Umbilical Vein Endothelial Cells (HUVEC) (A) and human 
colon adenocarcinona cell line HT29 (B) after 24 and 72 h exposure to 10 ng/mL or 1 
µg/mL BPA; (C) Western blotting detection of H3 dimethylation at lysine 9 (H3K9me2) 
and H3 trimethylation at lysine 4 (H3K4me3) on HT29 cells after 24 and 72 h exposure 
to 10 ng/mL or 1 µg/mL BPA showing a single 17 kDa band identical to that observed 
for cells grown in control medium or in medium supplemented with vehicle, α-tubulin 
was used as loading control; (D) L1-5' and L1-3' transcription levels on aging HUVEC 
at passage 12 (p12) after 72 h exposure to 1 µg/mL BPA. Results in (A), (B), and (D) 
are shown as the mean log2 fold change (2−∆∆Ct) ± standard deviation in relation to 
equivalent cells exposed to vehicle alone. Values significantly different from vehicle are 
indicated Student’s t test **p < 0.01 and *p < 0.05. 
 
4.4.2 Continuous BPA exposure reduces viability in aging HUVEC. 
Despite the fact that human exposure to BPA is continuous throughout life, up 
to now a single study on mammary epithelial cells evaluated BPA effects in 
cellular senescence (Qin et al. 2012). Here, we analyzed BPA effects in cellular 
viability of aging HUVEC. At passage 12, HUVEC were exposed to BPA for 72 
h or subjected to continuous BPA exposure for seven additional passages until 
passage 19 (p19). For comparison purposes, additional passages were 
performed regardless of the confluence level and cells were seeded at the 
same density for all passages/treatments. Equivalent cells were maintained for 
A B 
C D 
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the same periods in medium supplemented with vehicle. The results are 
presented in relation to cells maintained under standard conditions (Figure 2A). 
There were no considerable effects in cellular viability for vehicle (ethanol) in 
relation to control for any of the conditions assayed. More importantly, no 
significant variation in viability was detected after 72 h of BPA exposure at 
passage 12. Similarly at passage 15 (p15), corresponding to 384 h of 
continuous BPA exposure, no significant variation was detected between 
controls and treatments. Interestingly, at this passage a higher level of variation 
was detected independently of the growth medium, suggesting a transition 
phase in the senescence process. Conversely, both BPA concentrations tested 
induced a significant decrease in cellular viability for the longer periods, 528 h - 
passage 17 (p17) (−23.58% ± 4.80% and −26.60% ± 2.71%, for BPA 10 ng/mL 
and 1 µg/mL, respectively) and 693 h - passage 19 (−37.12% ± 1.83% and 
−26.26% ± 2.35%, for BPA 10 ng/mL and 1 µg/mL, respectively) (Figure 2A), 
indicating that concentrations found in humans as a result of environmental 
exposure may affect aging of vascular endothelial cells.  
A decline in cellular proliferation after prolonged culture is a common feature of 
primary cells associated with G0 arrest (Hwang et al. 2009), and in HUVEC this 
is accompanied by increased spontaneous apoptosis and polyploidization 
(Wagner et al. 2001). Our results clearly indicate significant decreases in 
proliferation capacity between passages 12 and 19 (Figure 2B). This is evident 
as significantly lower fluorescence emission at passage 19 for all growth 
conditions, which indicates decreased numbers of viable cells. Relevantly, this 
reduction in viable cells is more aggravated in BPA treated cells, showing that 
prolonged BPA exposure enhances this aging related phenotype. 
Cellular morphology and cytoskeleton organization was compared between 
non-senescent (passage 6) and senescent cells (passage 19). As aging cells 
cease to divide, there is the emergence of several distinctive changes in 
morphology, motility and mechanical strength along with cytoskeleton 
alterations, such as an increase in microtubules (Hwang et al. 2009; Wang and 
Gundersen 1984). Immunodetection of α-tubulin clearly revealed a distinct 
morphology between young and aging HUVEC (Figure 2C). Senescent cells 
show augmented surface area, enlarged nuclear size, stellate outlines, and 
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microtubules enrichment, as previously described (van der Loo et al. 1998). 
Even though BPA can directly target tubulin (George et al. 2008) and disturb 
mitotic cytoskeleton on actively dividing HUVEC (Ribeiro-Varandas et al. 2013), 
it does not affect cytoskeleton organization on aging HUVEC. Although our 
cytological results did not identify alterations in cell morphology associated with 
BPA exposure, BPA induced effects on cell viability are supported by evident 
decreases in cell density at the later passage (Figure 2C). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Evaluation of BPA exposure effects on cellular viability and morphology on aging 
HUVEC cells. (A) Variation in cell viability after 72 h exposure (passage 12, p12), 384 h 
(passage 15, p15), 528 h (passage 17, p17) and 693 h (passage 19, p19) of exposure to 
vehicle, BPA 10 ng/mL and BPA 1 µg/mL. Results are presented as percentage of variation 
in relation to equivalent cells maintained in standard medium (control). Student’s t test * p < 
0.01 in relation to control; (B) Comparison of fluorescence intensity at 590 nm (excitation 
wavelength, 560 nm) between passage 12 and 19 for all culture conditions assayed. 
Results are presented as mean ± standard deviation. Student’s t test * p < 0.001. Data in 
(A) and (B) result from cultivation and viability procedures performed simultaneously for all 
growth conditions; the same seeding density was used in all passages and growth 
conditions; (C) Cell morphology analysis after in situ detection of α-tubulin (red) and DNA 
DAPI staining (blue) in young proliferative HUVEC (P6, upper panel) and aging HUVEC 
(P19, lower panels). Young proliferative HUVEC were exposed to either BPA concentration 
or vehicle for 72 h at passage 6; aging cells were analyzed at passage 19 after continuous 
exposure from passage 12. Scale bars = 50 µm.  
a b A B 
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4.4.3 Continuous BPA exposure induces differential gene expression in 
aging HUVEC. 
Stress-induced senescence is associated with modifications in gene expression 
profiles (Dumont et al. 2002; Toussaint et al. 2000). In order to analyze the 
effects of 1 µg/mL BPA short and continuous exposure, qRT-PCR was utilized 
to evaluate the expression levels of seven genes on young (p6) and aging (p12 
and p19) HUVEC. Four genes for which transcription is altered in replicative 
senescence were selected, namely two major extracellular matrix proteins 
coding genes, osteonectin (SPARC) and fibronectin (FN1), and two regulators 
of cell fate, p21 and FOS, (Debacq-Chainiaux et al. 2008; Wagner et al. 2001). 
The apoptotic gene bcl-xL was also evaluated, since BPA exposure has been 
associated to alterations of transcriptional expression of apoptotic related genes 
in several cell lines (Buterin et al. 2006; Naciff et al. 2010) and age-related 
increase in programmed cell death was shown to occur in HUVEC cells 
(Wagner et al. 2001). Lastly, given that nucleolus is one of the most frequent 
cellular structures associated with human premature aging syndromes, 
nucleolin gene (NCL) and 18S rRNA transcription levels were also analyzed 
(Puzianowska-Kuznicka and Kuznicki 2005). Short (72 h) exposure was 
evaluated in young cells (p6) and aging cells (p12) (Figure 3A) whereas 
continuous exposure was evaluated in aging cells maintained in the presence of 
BPA from passage 12 to passage 19 (p19) (Figure 3B). Results are presented in 
comparison to equivalent cells grown in medium supplemented with vehicle as 
mean log2 fold change ± standard deviation. 
In young HUVEC (p6) 72 h exposure to 1 µg/mL BPA resulted, as we previously  
reported (Ribeiro-Varandas E. 2012), in a slight up-regulation of NCL gene 
(0.308 ± 0.340), which encodes for nucleolin a multifunctional protein 
associated ribosome biogenesis as well as to several other RNA regulatory 
mechanisms with proliferative and survival effects (Abdelmohsen et al. 2012). 
Inversely, in aging cells (p12) the same BPA exposure resulted in a significant 
decrease of p21 (−0.41 ± 0.166) and bcl-xL (−0.49 ± 0.352) transcription levels. 
The down-regulation of both genes suggests a lower capacity of aging cells to 
respond to damage, as p21 is a CDK inhibitor with a well established role in 
growth arrest in response to cell injury (de Camé Trécesson et al. 2011; Kim et 
al. 2001) and bcl-xL encodes for a transmembrane mitochondria protein with 
 ______________________________________________________________________ 
______________________________________________________________________ 
57 
 
anti-apoptotic function (Michels et al. 2013). Seventy-two-hour BPA exposure of 
aging cells does not result in immediate effects on cell viability (Figure 2A) as 
we have also reported for young HUVEC cells (Ribeiro-Varandas et al. 2013). 
However, continuous BPA exposure of aging HUVEC cells (693 h, p19) result in 
significant decrease in cell viability accompanied by significant down-regulation 
of the mRNA levels of both FOS (−0.884 ± 0.319) and 18S rDNA (−0.801 ± 
0.588) FOS is a component of the AP-1 transcription factor that regulates 
distinct cellular processes including cell proliferation, death, survival and 
differentiation (Hess et al. 2004) and under stress conditions regulation of 
ribosome biosynthesis is one of the cellular strategies to preserve homeostasis 
(Boulon et al. 2010). The large variation (standard deviation) associated with the 
gene expression data is of particular interest, especially in regards to SPARC 
and NLC mRNA levels. Considering that the levels of variation between 
technical replicates were almost absent, this shows that BPA induces general 
and non-directional de-regulation of gene expression in senescent cells. This is 
further supported by the transcription analysis of L1 related sequences after 
continuous BPA exposure (693 h, p19) showing a decrease in L1-5' (−0.549 ± 
0.368) and an increase in L1-3' (1.115 ± 0.15) (Figure 3C). 
Overall, the gene transcription results obtained on senescent HUVEC 
continuously exposed to BPA clearly show that this chemical affects the aging 
process. HUVEC constitute an in vitro model in the investigation of 
atherosclerosis pathogenesis (Khaidakov et al. 2011), an intrinsically age-
related disease in which vascular senescence play a critical role (Andreassi 
2008). Relevantly, atherosclerosis has been related to both deficient endothelial 
cell turnover (Higashi et al. 2012) as well as increased cell death (Van Vre et al. 
2012). Moreover several epidemiologic studies indicate that circulating BPA is 
correlated with coronary and carotid atherosclerosis (Lind and Lind 2011; 
Melzer et al. 2010; Melzer et al. 2012). Overall, our results indicate that BPA 
may play a role in atherosclerosis induction by decreasing proliferation capacity 
in association with transcriptional de-regulation. 
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Figure 3 - Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) evaluation 
of osteonectin (SPARC), fibronectin (FN1), p21, FOS, bcl-xl, nucleolin (NCL) and 18S 
rRNA transcription on (A) young (p6) and aging (p12) HUVEC cells after 72 h of 1 
µg/mL BPA exposure and (B) aging HUVEC (p19) after prolonged (693 h) exposure to 
BPA 1 µg/mL; (C) L1-5' and L1-3' transcription levels on aging HUVEC after prolonged 
exposure to BPA 1 µg/mL (p19, 693 h). Results are shown as the mean log2 fold 
change (2−∆∆Ct) ± standard deviation in relation to cells from equivalent passages 
maintained in medium supplemented with vehicle. Student’s t test, **p < 0.01 and *p < 
0.05. 
 
 
4.5 Conclusion  
 
For the past years, bisphenol A (BPA) has been implicated in the etiology of 
several human pathologies and its effects extensively studied. However, the 
current available information regarding BPA effects on aging processes is still 
scarce. 
The present work demonstrates that BPA at low concentrations has the 
capacity to affect global transcription levels in both HT29 and HUVEC. 
Furthermore, we show for the first time that continuous exposure to BPA 
interferes with gene expression and severely decreases cellular viability in 
A 
B C 
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aging vascular endothelial cells. These results support the correlation between 
BPA and atherosclerosis related diseases reported in distinct epidemiological 
studies and increasing concerns regarding the adverse effects of BPA exposure 
on human health. 
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5 Bisphenol A at the reference level 
counteracts Doxorubicin transcriptional effects 
on cancer related genes in HT29 cells 
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level counteracts Doxorubicin transcriptional effects on cancer related genes in 
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5.1 Abstract 
 
Background: Human exposure to Bisphenol A (BPA) results mainly from 
ingestion of food and beverages. Information regarding BPA effects on colon 
cancer, one of the major causes of death in developed countries, is still scarce. 
Likewise, little is known about BPA drug interactions although its potential role 
in doxorubicin (DOX) chemoresistance has been suggested. 
Objective: This study aims to assess potential interactions between BPA and 
DOX on HT29 colon cancer cells. 
Methods: HT29 cell response was evaluated after exposure to BPA, DOX, or 
co-exposure to both chemicals. Transcription levels of several cancer-
associated genes (c-fos, AURKA, p21, bcl-xl and CLU) were quantified by qRT-
PCR and cell viability analyzed through resazurin assay. Apotosis induction and 
mitotic disruption were evaluated cytologicaly by TUNEL assay and DAPI 
staining, respectively. 
Results: Gene expression analysis shows that BPA exposure induces slight 
up-regulation exclusively of bcl-xl without affecting cell viability.  Sub-therapeutic 
DOX concentration (40 nM) results in highly altered c-fos, bcl-xl, and CLU 
transcript levels, and this is not affected by co-exposure with BPA. In contrast, 
therapeutic DOX concentration (4 µM) induced down-regulation of c-fos and up-
regulation of AURKA, p21 and CLU is counteracted by BPA, evident as similar 
transcript levels in co-exposed cells to those of control. Co-exposure with BPA 
slightly decreases apoptosis in relation to DOX 4 µM alone without affecting 
DOX-induced loss of cell viability.  
Conclusions: These results emphasize the necessity of a better understanding 
of BPA interactions particularly with chemotherapeutic agents in the context of 
risk assessment. 
 
5.2 Introduction 
 
Bisphenol A (BPA) is a plastic monomer and plasticizer used in a wide range of 
consumer products including food and drink containers and oral intake is 
accepted as being the main route of human exposure (Geens et al. 2012). 
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Although BPA is considered a weak environment estrogen due to its low affinity 
to classical nuclear estrogen receptors (ER) (Pennie et al. 1998), several 
findings reveal that BPA prompt very distinct responses through a variety of 
signaling pathways (Rubin 2011). BPA has been intensively studied in regard to 
carcinogenesis in hormone responsive organs (Soto and Sonnenschein 2010). 
However, an aspect poorly investigated is BPA potential interactions with 
chemotherapeutic drugs although there are some evidences of its counteracting 
effects. In breast cancer cells the anti-proliferative effects of distinct commonly 
used chemotherapeutic drugs namely doxorubicin (DOX), vinblastine, and 
cisplatin are antagonized by BPA and associated with increased levels of anti-
apoptotic proteins (LaPensee et al. 2009; 2010).  
On the other hand, colon cancer is one of the most common causes of death in 
industrialized countries (WHO 2014). Relevantly, colon cancer incidence is 
rising in developing countries reflecting dietary changes (Center et al. 2009) and 
likewise BPA human exposure is also increasing (Nahar et al. 2012). Even so, 
research on BPA effects on the intestinal tract has received little attention and is 
limited to few studies. BPA was shown to increase tight junction sealing in 
epithelial colon cells in rats (Braniste et al. 2010) and impair the estradiol 
inhibitory effect on proliferation of colon adenocarcinoma cells DLD-1 (Bolli et 
al. 2010). 
In the present study we aimed to evaluate effects of BPA on colon 
adenocarcinoma cell line HT29 and its interaction with DOX. Distinct cellular 
effects have been associated with DOX depending on concentration. Commonly 
used therapeutic dosages induce cell cycle arrest and apoptosis while lower 
concentrations are associated with mitotic disruption and senescence-like 
phenotypes (Eom et al. 2005; Park et al. 2007). Considering this, two DOX 
concentrations were assayed: a sub-therapeutic dosage for which interaction 
with BPA was previously reported (LaPensee et al. 2009) and a 100 fold higher 
concentration corresponding to a therapeutic level (Greene et al. 1983). 
Although human exposure to BPA is accepted as generalized the level of 
exposure is a matter of intense debate. In 1993 the U.S. Environmental 
Protection indicated as Reference Dose for Chronic Oral Exposure (RfD) for 
BPA 50 µg/kg body weight/day (EPA 1993) and in 2006 the European Food 
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Safety Authority set the same value as BPA Tolerable Daily Intake (TDI) (EFSA 
2006). Human exposure to BPA trough diet, estimated on migration values, 
point to a range of 0.4–4.2 µg/kg body weight/day (Geens et al. 2012) 
corresponding to approximately 100 to 10 fold less than the TDI. Such 
estimations are compatible with BPA levels detected in urine, however there is 
a discrepancy with biomonitoring studies that indicate the presence of 
unmetabolized BPA in human blood/serum in the range of 2–13 nmol/l (0.5–3 
ng/ml) (Vandenberg et al. 2010). Human studies in a limited number of 
individuals subjected to BPA oral exposure reveal however much lower levels of 
circulating BPA (Völkel et al. 2002; 2005). On the other hand, studies in non-
human primates point to the need of oral dosages higher than the TDI to reach 
blood levels identical to those found in humans (Fisher et al. 2011; Taylor et al. 
2011). Another point of debate in risk assessment is the fact that BPA 
undergoes extensive gut and liver glucuronidation and consequently only a 
small fraction of unmetabolized bioactive BPA enters the blood stream. BPA 
pharmacokinetic models are based in a rapid BPA glucuronidation and urinary 
clearance (Edginton and Ritter 2009; Fisher et al. 2011) but do not take into 
consideration potential local BPA deconjugation at particular tissues. β-
glucuronidase-mediated BPA deconjugation in placenta and fetal tissues has 
been suggested to contribute to considerable fetus exposure to free BPA 
(Ginsberg and Rice 2009). Significantly, extracellular β-glucuronidase levels are 
increased in most solid tumors microenvironment due to the inflammatory 
process and lysosomal release (Tranoy-Opalinski et al. 2014). In recent years, 
therapeutic approaches that specifically target tumors have taken advantage of 
this characteristic through the development of glucuronide prodrugs that are 
activated in the β-glucuronidase-rich microenvironment (Tranoy-Opalinski et al. 
2014). In contrast with other internal organs, for which exposure depends on 
circulating BPA, in the digestive tract additional contact with ingested BPA prior 
to its conjugation can contribute to the overall cell exposure. Considering the 
high level of uncertainty regarding BPA burden in intestinal tissues and 
particularly in tumors we choose to evaluate BPA effects at a concentration 
corresponding to the established guidance values and considered safe in terms 
of human exposure. Moreover, our previous results show that colon 
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adenocarcinoma cell line HT29 is not considerably affected by single exposure 
to this BPA concentration in terms of cell proliferation and transcription levels of 
cell cycle related genes (Ribeiro-Varandas et al. 2013). 
For gene transcription analysis five distinct genes were selected which are 
generally recognized as key players in cancer biology. Besides the anti-
apoptotic gene bcl-xl, for which increased expression was shown to occurs due 
to BPA/DOX interaction (LaPensee et al. 2009), p21, AURKA, c-fos and CLU 
were also analyzed. p21 gene product is a cyclin-dependent kinase inhibitor 
tightly connected with cell cycle progression and cancer outcome (Warfel and 
El-Deiry 2013). AURKA encodes for Aurora A, a mitotic key regulatory protein 
associated to cancer aggressiveness (Nikonova et al. 2013). The c-fos encoded 
protein is a component of the activator protein-1 (AP-1) transcription factor 
required for accurate regulation of several genes associated with cell 
proliferation, differentiation, apoptosis and oncogenic transformation 
(Durchdewald et al. 2009). CLU encodes for clusterin a multifunctional protein 
that has been implicated both in promotion of carcinogeneis as well as in tumor 
suppression (Mazzarelli et al. 2009; Pucci et al. 2009). Additionally to gene 
transcription analysis, cytological evaluation of apoptosis and mitotic disruption 
as well as cell viability assays were also carried for assessment of potential 
BPA/DOX interactions.  
 
5.3 Materials and Methods  
 
Cell culture and reagents.  
HT29 cells were purchased from ECACC and cultivated in 75cm2 flasks with 
RPMI media containing GlutaMAX™ I, 25 mM HEPES (Invitrogen), 
supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 mg/ml 
streptomycin and 2 mM L-glutamine. Cells cultures were maintained in a 5% 
(v/v) CO2 humidified atmosphere at 37°C. After subculture cells were allowed to 
stabilize for 24 h in standard growth medium before treatments.   
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Drugs and treatments.  
Bisphenol A (Sigma) was freshly diluted in ethanol and added to the culture 
media to the final concentration of 4.4 µM (1 µg/ml) that corresponds to the TDI 
considering an average body weight of 70 Kg and daily consumption of 3 liters 
of preformed water. Doxorubicin (AppliChem) was dissolved in water and added 
to the culture medium to final concentration of 40 nM (25 ng/ml) or 4 µM (2.5 
µg/ml), the later corresponding to free DOX concentration in blood in clinical 
cancer chemotherapy (Greene et al. 1983). For the combined BPA/DOX 
exposures cells were pre-exposed to BPA for 24 h followed by additional 24 h of 
simultaneous exposure to BPA and DOX. Correspondingly, for single drug 
exposures cells were incubated with BPA for 48 h after the 24 h stabilization 
period whereas for DOX standard medium was substituted for medium with 
DOX 48 h after subculture and maintained. For evaluation of cell recovery 
capacity after treatments cells were cultivated for additional 72 h in standard 
culture medium. Controls were performed for all experiments using cells grown 
in standard culture medium or in medium supplemented with ethanol 170 µM 
(vehicle concentration for BPA). 
 
Real-time PCR 
Transcriptional analysis was performed by quantitative real-time RT-PCR (qRT-
PCR) for c-fos, AURKA, p21, bcl-xl and CLU genes as well as control genes 
GAPDH and β-actin, using the specific primers listed in Table 1. Total RNA was 
extracted with the RNAqueous Kit (Invitrogen) following manufacturers´ 
instructions and 3 µg utilized for RNase free DNase digestion (RQ1 RNase free 
DNase, Promega).  cDNA synthesis was completed with random primers 
(DYNAmo cDNA syntesis Kit, Thermo Scientific) and utilized for qRT-PCR with 
SsoFast Eva Green Supermix (BioRad) utilizing the following conditions: 95 ◦C 
for 3 min, 35 cycles (95 ◦C for 30 s, 55 ◦C for 30 s, 72 ◦C for 40 s), and 72 ◦C for 
5 min. To ensure that genomic DNA was completely absent prior to cDNA 
synthesis, PCRs were performed with 18S rDNA primers and 250 ng of DNase 
digested RNA. Control PCRs were also performed for all primer combinations 
without template. Denaturation curves were observed to ensure correct 
amplification products. Since no significant differences were detected between 
 ______________________________________________________________________ 
______________________________________________________________________ 
68 
 
the two reference genes, threshold cycles (Ct) of the target genes were 
equilibrated with the mean Ct of GAPDH and β-actin genes to calculate ∆Ct 
(∆Ct = Ct target – mean Ct GAPDH:β-actin). Gene expression levels were 
analyzed by calculating ∆∆Ct (∆∆Ct = ∆Ct treatment – mean ∆Ct control). 
Results are presented as log2 of the mean fold change (2-∆∆Ct) ± standard 
deviation.  
 
Table 1 Primers used for qRT-PCR.  
Gene Accession nº Forward primer (5´→3´) Reverse primer (5´→3´) Product 
size (bp) 
AURKA NM_003600 GCTGGAGAGCTTAAAATTGCAG TTTTGTAGGTCTCTTGGTATGTG 220 
c-fos   NM_005252 AGGAGAATCCGAAGGGAAAG  CAAGGGAAGCCACAGACATC  247 
p21 NM_000389 CTGGAGACTCTCAGGGTCGAA CCAGGACTGCAGGCTTCCT 123 
bcl-xl  Z23115.1 TTACCTGAATGACCACCTA ATTTCCGACTGAAGAGTGA 185 
CLU  NM_001831 GGATGAAGGACCAGTGTGACAAG CAGCGACCTGGAGGGATTC 114 
GAPDH  NM_002046 GAGTCAACGGATTTGGTCGTA GCAGAGATGATGACCCTTTTG 245 
β-Actin   NM_001101 GGTCATCTTCTCGCGGTTGGCCTTGGGGT CCCCAGGCACCAGGGCGTGAT 230 
a
 GenBank accession numbers (National Center for Biotechnology). 
 
Cytotoxicity assay.  
Cell viability was evaluated by resazurin assay (CellTiter-Blue, Promega) 
following manufacturer’s instructions and fluorescence emission measured with 
a microplate reader (Synergy HT, BioTek). Cells were plated on 96-well dishes 
at a density of 3.2 × 104 cells/well.  
 
TUNEL assay.  
For cell death assessment, cells were grown over glass coverslips coated with 
0.2% (v/v) gelatin (Sigma) and after treatments fixed in 4% (p/v) formaldehyde 
in PBS for 10 min at room temperature and subsequently TUNEL assay 
(Roche) was performed accordingly to manufacturers´ instructions followed by 
DAPI staining.  
 
Cytology analysis of mitosis.  
Cells were cultivated on Petri dishes as above. After treatments cells were fixed 
in 4% (p/v) formaldehyde in PBS for 10 min at room temperature and DAPI 
stained for evaluation mitotic index and mitotic anomalies.  
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Data analysis.  
All experiments were repeated at least three times with at least three replicates 
per experiment. For all parameters analyzed no significant differences were 
obtained between cells grown in standard medium or in ethanol-supplemented 
medium, the pooled results are and indicated as control. χ2 test was used for 
analysis of relative occurrence of distinct types of mitotic anomalies. Student´s t 
test was used for analysis of cellular viability, frequency of apoptotic bodies, 
mitotic index and qRT-PCR gene transcription analysis. Additionally, for qRT-
PCR data only differences in transcription levels higher than 1 for the mean log2 
fold change (corresponding to a difference in one PCR cycle and a value of 2 
for the Fold Change) were considered for statistical analysis.  
 
5.4 Results 
 
5.4.1 BPA at reference level increases transcription of bcl-xl.  
Transcription levels were analyzed for cancer related genes c-fos, AURKA, p21, 
bcl-xl and CLU in HT29 cells exposed to BPA at a concentration corresponding 
to the TDI level (4.4 µM) during 48 h. Figure 1A shows that BPA exposure did 
not alter mRNA levels of c-fos, AURKA, p21 and CLU genes. Conversely, after 
exposure to BPA an up-regulation was detected for the antiapototic gene bcl-xl 
corresponding to transcript duplication in relation to control (log2 fold change 
1.1 ± 0.68). 
 
5.4.2 BPA does not affect gene expression alterations induced by low 
DOX concentration. 
HT29 cells exposure to DOX alone at sub-therapeutic concentration (40 nM) for 
24 h revealed a clear effect on transcription levels of distinct genes. Although 
AURKA and p21 genes were not affected by DOX, the levels of c-fos, bcl-xl and 
CLU were significantly altered (Figure 1B). CLU transcript level was strongly 
increased (log2 fold change 2.84 ± 0.12) by DOX 40 nM whereas c-fos showed 
a severe down-regulation (log2 fold change -4.73 ± 0.35) that was also patent 
for bcl-xl although at a minor extent (log2 fold change -1.96 ± 0.32). 
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Combined exposure to BPA 4.4 µM and DOX 40 nM, corresponding to 24 h pre-
exposure to BPA alone followed by additional 24 h of simultaneous exposure to 
BPA and DOX, resulted in altered gene transcription patterns in relation to 
control but similar to that obtained for DOX 40 nM alone (Figure 1B).  
 
5.4.3 Gene expression alterations induced by DOX at therapeutic 
concentration are reverted by BPA. 
Exposure of HT29 cells to DOX therapeutic concentration (4 µM) for 24 h 
resulted in a significant variation in relation to control for four of the five genes 
analyzed; only bcl-xl gene transcription was not noticeably altered (Figure 1C). 
c-fos was significantly down-regulated (log2 fold change 3.04 ± 0.40), whereas 
AURKA, p21 and CLU were up-regulated with a particularly prominent increase 
for CLU gene transcripts (Log2 fold change of 1.53 ± 0.36, 2.05 ± 1.09 and 5.99 
± 0.18 for AURKA, p21 and CLU, respectively). Strikingly, pre-exposure to BPA 
(4 µM) for 24 h and subsequent 24 h combined exposure to BPA and DOX at 
therapeutic concentration (4 µM) resulted in significant changes in transcription 
for all genes analyzed in relation to DOX 4 µM alone (Figure 1C). A reversal of 
the effects induced by DOX therapeutic concentration was observed with BPA 
combined exposure. The four genes (c-fos, AURKA, p21 and CLU) for which 
transcription was altered by DOX 4 µM, showed transcription levels identical to 
those observed in the control after exposure to BPA/DOX 4 µM. Only for bcl-xl 
no major variation was observed between DOX 4 µM alone and BPA/DOX 4 µM 
or between both treatments and control (log2 fold change -0.7 ± 0.51 and 0.51 ± 
0.29 for DOX 4 µM and BPA/DOX 4 µM, respectively).  
 
5.4.4 DOX sub-therapeutic and therapeutic concentrations have 
differential effects on gene transcription. 
Comparative analyses of DOX exposure alone on gene transcription levels 
revealed significant differences in the effects of both DOX concentrations 
assayed for all genes analyzed (p<0.001 for each gene between DOX 40 nM 
and DOX 4 µM) (Figure 1B and C). For the lower DOX concentration (40 nM) 
bcl-xl transcription was significantly reduced in relation to control but no relevant 
alteration was detected for the higher concentration (4 µM). Contrarily, both 
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AURKA and p21 were significantly up-regulated for the higher concentration 
DOX with no considerable effect for the lower concentration. c-fos transcript 
level was reduced in both concentrations but much more strongly for DOX 40 
nM. Both DOX concentrations lead to an increase in CLU transcription level 
however much more pronounced for DOX 4 µM. 
 
A                                           B                                                C 
 
 
 
 
 
 
Figure 1 -  BPA effect on HT29 gene transcription. c-fos, AURKA, p21 bcl-xl and CLU 
gene transcription analysis after exposure to (A) BPA 4.4 µM, (B) DOX 40 nM alone 
and in combination with BPA and (C) DOX 4 µM alone and in combination with BPA. 
Results are shown as average mean log 2 fold change ± standard deviation.  
* p < 0.0001 for Student´s t test for comparison between treatments and control or 
between distinct treatments (indicated by horizontal brackets). 
 
5.4.5 BPA decreases DOX-induced apoptosis without immediate effects 
on cell viability.  
Considering that DOX effect on apoposis is dependent on concentration and the 
differential results obtained between treatments for bcl-xl transcript levels, an 
evaluation of apoptosis was performed by TUNEL assay. TUNEL positive cells 
were virtually absent after exposure to BPA alone or to 40 nM DOX either alone 
or in combination with BPA. On the other hand, 4 µM DOX and BPA/DOX 4 µM 
resulted in the formation of typical TUNEL positive apoptotic bodies (Figure 2A). 
However comparison of apoptotic bodies frequency between 4 µM DOX and 
BPA/DOX 4 µM revealed a slightly but significant reduction associated with the 
BPA/DOX combined exposure (Figure 2B).  
Effects on cell viability were accessed trough Resazurin assay immediately after 
treatments as well as after 72 h recovery in standard medium. No significant 
variation on cell viability was detected between treatments and control 
immediately after exposure (data not shown). The results obtained for all 
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treatments after recovery in drug free medium are presented in Figure 3 
expressed as percentage in relation to control. No significant differences in cell 
viability were detected associated with exposure to BPA alone or to the lower 
DOX concentration (40 nM) either alone or combined with BPA. On the other 
hand a strong decrease in cell viability was detected for cells exposed to the 
higher DOX concentration (4 µM) either as single exposure or combination with 
BPA, with no significant difference between both treatments.  
 
 
 
 
 
 
 
 
 
 
Figure 2 - BPA decreases DOX induced apoptotic bodies. (A) TUNEL positive nuclei 
(green) after exposure to DOX 4 µM alone and after BPA/DOX 4 µM combined 
exposure, merged images with DNA DAPI staining (blue) are shown on the right,  
bar = 5 µm. (B) Percentage of apoptotic bodies after exposure to DOX 4 µM and 
BPA/DOX 4 µM. The total number of cells analyzed is shown in brackets. * p < 0.05 for 
Student´s t test between treatments. 
 
 
 
 
Figure 3 - DOX effect on cell viability is not affected by co-exposure with BPA. Cell 
viability after 72 h recovery in drug free medium following exposure to BPA,  
DOX (40 nM or 4 µM) and BPA/DOX (40 nM or 4 µM) co-exposure. Results are 
presented as percentage of variation over control, * p < 0.01 for Student´s t test in 
relation to control. 
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5.4.6 BPA does not affect mitotic disruption induced by DOX.  
Mitotic disruption was also evaluated through cytological analysis after DNA 
DAPI staining immediately after treatments. The mitotic index was determined 
for all conditions assayed. Exposure to DOX 4 µM either alone or in 
combination with BPA resulted in cell cycle arrest reflected by the complete 
absence of mitotic cells (Figure 4A). On the other hand, no significant difference 
in the mitotic index in relation to control was detected for BPA 4.4 µM alone. 
Conversely, a reduction in the percentage of mitotic cells was observed after 
exposure to DOX 40 nM and identically for BPA/DOX 40 nM (Figure 4A). 
Quantification of abnormal mitotic cells revealed moreover an increase in 
relation to control associated with exposure to BPA, DOX 40 nM and BPA/DOX 
40 nM. The mitotic abnormalities were further characterized accordingly with the 
phenotype observed as multipolar metaphases, anaphase bridges and lagging 
chromosomes (or chromosome fragments) (Figure 4B, i, ii and iii). Interestingly, 
the relative proportion of these types of mitotic anomalies was distinct between 
treatments (Figure 4B). For BPA exposure alone multipolar metaphases were 
predominant (79.4%), anaphase bridges were also frequent (20.6%) but lagging 
chromosomes were not detected. On the other hand, for exposure to DOX 40 
nM, alone or in combination with BPA, anaphase bridges were prevalent (83.9% 
and 80.0%, for DOX 40 nM and BPA/DOX 40 nM, respectively), although some 
multipolar metaphases (12.9%, and 17.1%) and few chromosome fragments 
(3.2% and 2.9%) were also detected.  
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Figure 4 - DOX induced mitotic disruption is not affected by BPA. (A) Mitotic index and 
mitotic anomalies in control medium and after BPA, DOX 40 nM and DOX 4 µM 
exposure alone or BPA/DOX  (40 nM or 4 µM) co-exposure. * p < 0.01 and ** p < 0.001 
for Student´s t test in relation to control, total numbers of cells analyzed showed in 
brackets. (B) Quantification of distinct mitotic anomalies associated with DOX, BPA 
and combined BPA/DOX exposures. DAPI stained anomalous mitotic cells are shown 
on the left: (i) multipolar metaphase, (ii) anaphase bridges and (iii) lagging 
chromosomes, bar = 5 µm. Graphic on right shows the relative percentage of the 
different types of mitotic anomalies. At least 50 anomalous mitosis were analyzed for 
each treatment, * p < 0.0001 for χ2 test for BPA exposure alone in relation to DOX 40 
nM and BPA/DOX 40 nM. 
 
5.5 Discussion 
 
The present study shows that BPA at reference level (TDI) elicit very distinct 
cellular responses in HT29 colon adenocarcinoma cells when combined with 
DOX at low concentration (sub-therapeutic level) or when combined with DOX 
at high concentration (therapeutic level). Exposure to BPA alone does not alter 
cell viability but induces a slight up-regulation of the anti-apoptotic gene bcl-xl. It 
has been previously shown that BPA increases expression of anti-apoptotic 
genes in breast and ovarian cancer cells, although at lower concentrations and 
associated with increased cell proliferation (LaPensee et al. 2009; Ptak et al. 
2011). On the other hand, we have demonstrated before that BPA at TDI level 
as well as at a lower concentration compatible with those found in humans do 
not alter cell proliferation of HT29 but also of primary Human Umbilical Vein 
Endothelial Cells (HUVEC) (Ribeiro-Varandas et al. 2013). Nonetheless, gene 
transcription analysis of cell cycle related genes revealed that HT29 are less 
sensible to BPA than HUVEC independently of BPA concentration, although 
both cell types are ERβ positive and HT29 additionally expresses the 
 
A                                                  B 
 ______________________________________________________________________ 
______________________________________________________________________ 
75 
 
membrane bound G protein-coupled estrogen receptor 1 (Ribeiro-Varandas et 
al. 2013). Therefore, BPA induction of bcl-xl in HT-29 cells suggests that this is 
a common feature of cellular response to BPA exposure independent of its 
positive effect on cell proliferation. 
DOX triggers apoptosis at typical therapeutic doses but not at lower 
concentrations (Eom et al. 2005; Park et al. 2007). In a hepatocellular 
carcinoma it was demonstrated that DOX high concentration (20 µM) leads to 
apoptosis whereas DOX low concentration (100 nM) induces a senescence-like 
phenotype and mitotic catastrophe (Eom et al. 2005). It was also shown that 
over expression of bcl-xl does not block low dose DOX effects but impairs 
apoptosis induced by high concentration of DOX (Park et al. 2007). Here we 
show that sub-therapeutic DOX (40 nM) induces down-regulation of bcl-xl and 
an increase in mitotic anomalies in HT29 cells but not occurrence of apoptotic 
bodies with no effects on cell viability. A strong down-regulation of c-fos is also 
induced by DOX 40 nM concentration. C-fos is a member of the AP-1 
transcription factor complex that was shown to promote bcl-xl transcription 
(Salameh et al. 2010). These observations indicate that also in colon 
adenocarcinoma HT29 cells DOX at low concentration induces mitotic 
disruption but not apoptosis. 
On the other hand, the present results also show that exposure of HT29 to high 
DOX concentration (4 µM) results in cell viability decrease and apoptosis 
induction, without significant alteration in bcl-xl mRNA level. However, this DOX 
concentration induces marked transcriptional alterations in the other four genes 
analyzed. C-fos is down-regulated, as for DOX low concentration although to a 
lesser extent. Conversely, the mRNA levels of AURKA and p21 are increased 
by DOX 4 µM what is compatible with the observed induction of cell cycle 
arrest. DOX at high concentrations is known to induce G2/M block through p21 
induction in several cell lines (Kim et al. 2009; Venkatakrishnan et al. 2008) 
what correlates with AURKA mRNA increase since AURKA transcription peaks 
at G2/M phase of the cell cycle (Tanaka et al. 2002). Cell sensitivity to DOX is 
correlated with the level of p21 induction being higher for cells with functional 
p53, however it occurs also in HT29 cells that carry a p53 mutation through a 
independent pathway (Ravizza et al. 2004).  
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The present work further demonstrates that the same BPA concentration, 
corresponding to the TDI level, has very distinct interaction outcomes with DOX 
at sub-therapeutic and therapeutic dosages. The HT29 response to DOX low 
concentration is not altered by co-exposure with BPA either at gene 
transcription level, cell viability or mitotic disruption. We have previously shown 
in HUVEC cells that BPA exposure alone leads to spindle anomalies and 
formation of multipolar metaphases (Ribeiro-Varandas et al. 2013). The present 
results show also a predominance of multipolar metaphases in HT29 cells 
exposed to BPA alone this effect is however masked by co-exposure with DOX 
40 nM as the type of mitotic anomalies is identical to that of DOX 40 nM alone 
with predominance of anaphase bridges. 
More importantly, the present results show that BPA at TDI level counteracts 
effects of DOX therapeutic dose on gene expression in colon adenocarcinoma 
cell line HT29 without short-term effects on cell viability. Although co-exposure 
with BPA is associated with a decrease in apoptotic cells, it does not alter the 
DOX 4 µM induced cell cycle arrest or loss of cell viability after drug removal. 
The slight reduction of apoptotic cells might not have a direct impact on overall 
cell viability and this effect of BPA/DOX 4 µM might be related with a small 
increment in the bcl-xl mRNA level in relation to DOX alone, although the 
difference in the transcription level is below the threshold established that 
corresponds to a 2-fold change. More puzzling is however that the DOX 4 µM 
induced cell arrest is not altered by combined exposure with BPA although 
transcription levels of both p21 and AURKA are severely decreased in relation 
to DOX 4 µM alone. For the BPA/DOX combination the mRNA levels of both 
p21 and AURKA are slightly above the control but this increase is below the 2-
fold change threshold. If for DOX 4 µM alone the observed cell cycle arrest can 
be directly associated with p21 induction, it is more difficult to understand that 
an identical result is obtained for the much lower level of p21 detected after co-
exposure to BPA/DOX and that this is also accompanied by a decrease in 
AURKA transcription in relation to DOX alone. 
Significantly, the BPA counteracting effect of DOX 4 µM on gene expression is 
not limited to the cell cycle related genes p21 and AURKA but also observed for 
the AP-1 transcription factor component c-fos as well as for CLU, which 
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encodes a multifunction protein. It is noteworthy that independently of DOX 
induced up- or down-regulation, the transcription levels of these four genes after 
combined exposure to BPA and DOX are similar to those of control. It can be 
argued that the transcription deregulation of components of transcription factors 
as c-fos may result in deregulation of other genes. It has been suggested that c-
fos acts as transcriptional repressor of CLU (Jin and Howe 1999) and c-fos and 
p21 levels have also shown to be inversely correlated in colonic epithelial cells 
associated with prolonged oxidative stress (Poehlmann et al. 2013). This raises 
the hypothesis that restoration to near control levels of p21 and CLU mRNA 
levels in BPA/DOX 4 µM combination could result from the effect on c-fos 
transcription. However, a fundamental question remains unanswered: how BPA 
alters DOX induced deregulation of the transcription factors? The understanding 
of the mechanism underlying this interaction between BPA and DOX is out of 
the scope of this work but certainly a most important and complex problem. The 
mechanisms of action of BPA per se are not yet fully understood and although 
BPA is generally characterized as a xenoestrogen there is increasing evidences 
that can affect a variety of cellular pathways not necessarily mediated by classic 
estrogen receptors (Rubin 2011). Nonetheless, the present work demonstrates 
that BPA alters the transcriptional response to therapeutic DOX concentration of 
four genes for which there is vast literature establishing their key functions in 
cancer biology. As example it is worth noticing some of the more recent 
research regarding colon cancer. In colon cancer stem cells it was shown that 
siRNA knockdown of c-fos results in the up-regulation of other transcription 
factors, namely NANOG, OCT3/4, and SOX2 with important roles in maintaining 
cell pluripotency and self-renewal (Apostolou et al. 2013). In a distinct 
approach, an epidemiological study involving 386 stage II and III colon cancer 
patients revealed that disease free survival post surgical resection is positively 
related with high levels of p21 and low levels of AURKA and that for stage III 
cancers with AURKA overexpression recurrence is potentiated by 
chemotherapy (Belt et al. 2012). On the other hand, CLU has received 
particular attention due to its implication in cancer progression, prognosis and 
chemoresistance, (Mazzarelli et al. 2009; Pucci et al. 2009). Interestingly, it was 
recently shown that ERβ signaling can indirectly increase CLU mRNA levels 
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through miRNA regulation (Edvardsson et al. 2013). Carcinogenesis, cancer 
progression, treatment response and disease outcome are undoubtedly 
dependent on gene expression patterns of malignant cells. The present results 
demonstrate that gene transcription response to DOX can be altered by BPA 
emphasizing the necessity to address effects of BPA interactions in terms of 
human health risk assessment.  
 
5.6 Conclusion 
 
Overall the data here presented reveals that BPA can alter the effect of DOX on 
transcript levels of crucial genes involved in cancer biology. Moreover, the 
ability of BPA to interact with DOX is dependent on DOX concentration and thus 
of the cellular processes affected by DOX with evident interaction effects 
restricted to the therapeutic relevant DOX concentration. Although we do not 
detect any differences in cell viability associated with BPA/DOX interaction long-
term consequences on cell fate cannot be excluded. Taken together, the results 
presented here clearly reveal that it is essential to take into account the effects 
of interactions in BPA risk assessment, particularly in the context of 
chemotherapy.  
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6.1 Abstract 
 
Background: Eupatorium cannabinum L. has long been utilized in traditional 
medicine, however no information is available regarding cellular effects of full 
extracts. The present work aimed to assess the effects of E. cannabinum 
ethanolic extract (EcEE) on the colon cancer line HT29 as well as to evaluate 
potential interactions with bisphenol A (BPA) a synthetic phenolic compound to 
which humans are generally exposed and doxorubicin (DOX) a commonly used 
chemotherapeutic agent.  
Methods: HT29 cells were exposed to different concentrations (0.5 to 50 µg/ml) 
of EcEE alone or in combination with BPA or DOX. Cell viability was analyzed 
through resazurin assay. Gene transcription levels for NCL, FOS, p21, AURKA 
and bcl-xl were determined through qRT-PCR. Cytological analysis included 
evaluation of nuclear and mitotic anomalies after DAPI staining, 
immunodetection of histone H3 lysine 9 acetylation (H3K9ac) and assessment 
of DNA damage by TUNEL assay.  
Results: Severe loss of HT29 cell viability was detected for 50 µg/ml EcEE 
immediately after 24 h of exposure whereas the lower concentrations assayed 
(0.5, 5 and 25 µg/ml) resulted in significant viability decreases only after 96 h. 
Exposure to 25 µg/ml EcEE for 48 h resulted in irreversible cell damage leading 
to a drastic decrease in cell viability after 72 h recovery in EcEE-free medium. 
The 48 h 25 µg/ml EcEE treatment also induced alteration of colony 
morphology, H3K9 hyperacetylation, transcriptional up regulation of p21 and 
down regulation of NCL, FOS and AURKA, indicating reduced proliferation 
capacity. This treatment also resulted in drastic mitotic and nuclear disruption 
denoting induction of cell death. However, this was accompanied by up-
regulation of bcl-xl, limited TUNEL labeling and nuclear size increase 
suggestive of a non-apoptocic cell death pathway. EcEE/BPA co-exposure 
increased mitotic anomalies particularly for the lowest EcEE concentration, 
although without major effects on viability. Conversely, EcEE/DOX co-exposure 
decreased cell viability in relation to DOX for all EcEE concentrations, without 
affecting the DOX-induced cell cycle arrest.  
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Conclusions: EcEE has effective cytotoxic activity on HT29 cancer cells 
leading to mitotic disruption and non-apoptotic cell death without severe 
induction of DNA damage. Interactions experiments showed that EcEE can 
increase BPA aneugenic effects. On the other hand, EcEE synergistic effects 
with DOX support a potential use as adjuvant in chemotherapeutic approaches.  
 
6.2 Introduction 
 
Eupatorium cannabinum L., commonly known as hemp-agrimony is a robust 
perennial herbaceous plant of the Asteraceae family, the only species of the 
Eupatorium genus found in Europe occurring also throughout North Africa and 
Asia (Schmidt and Schilling 2000). E. cannabinum has long been used for 
medicinal proposes being referred by Greeks and Romans as well by the 
medieval Persian physician Aviccena, for what is also known as Eupatorium of 
Aviccena, and later in by the Portuguese Renaissance pioneer in tropical 
medicine Garcia da Orta (1563). Presently, hemp-agrimnony is used in both 
Chinese (Fu et al. 2002) and Indian (Roeder and Wiedenfeld 2013) traditional 
medicines as well as in natural medicine in western countries (Kozel 1982) with 
very diverse therapeutic indications including influenza-like illnesses (Jaric et al. 
2007), hypertension (Fu et al. 2002; Jaric et al. 2007; Roeder and Wiedenfeld 
2013) and as an antitumoural agent (Roeder and Wiedenfeld 2013). E. 
cannabinum  extracts has been previously characterized revealing the presence 
of sesquiterpenes (Rucker et al. 1997), pyrrolizidine alkaloids (Boppre et al. 
2008; Fu et al. 2002) as well as several phenolic compounds (Chen et al. 2011; 
Zhang et al. 2008). 
Sesquiterpenes were found to be a major fraction (43.3%) of essential oil from 
E. cannabinum aerial parts (Paolini et al. 2005), being eupatoriopicrin the main 
component (Rucker et al. 1997). Eupatoriopicrin has been associated with 
induction DNA damage in Ehrlich ascites tumour (Woerdenbag et al. 1989b) as 
well as with cytostatic activity and tumour growth inhibition proprieties in Lewis 
lung carcinoma and FIG26 fibrosarcoma both in vitro and in vivo (Woerdenbag 
et al. 1989a).  
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Pyrrolizidine alkaloids are generally associated with genotoxicity and 
tumourigenic activities (Fu et al. 2004), however the isomers intermedine and 
lycopsamine indentified in E. cannabinum have low genotoxic potency (Chen et 
al. 2010) and lycopsamine was shown to be non-tumourigenic in rats (Xia et al. 
2013). Additionally the phenolic compounds identified in this plant have been 
described to have anti-inflammatory (Chen et al. 2011), anti-parasitary (Sulsen 
et al. 2007), as well as anti-proliferative effects in several cell lines (Forgo et al. 
2012). In particular, jaceosidin cytotoxic effects have been demonstrated in 
normal and cancer endometrial cells (Lee et al. 2013) and hispidulin was shown 
to efficiently inhibit growth of gastric cancer cells (Yu et al. 2013) and liver 
carcinoma cells without significant toxic effect in normal liver cells (Gao et al. 
2013).  
Although the effects of specific components of Eupatorium cannabinum L. 
extracts have been described, the cellular effects of the full extracts have not, 
until now, been investigated. Thus, here we evaluated the effects of different 
concentrations of Eupatorium cannabinum L. ethanolic extract (EcEE) in the 
colon cancer cell line HT29. Moreover we also analyzed its interactions with the 
synthetic phenolic compound bisphenol A (BPA) as well as with the 
chemotherapeutic agent Doxorubicin (DOX). Human exposure to BPA is 
considered generalized in the common population and its adverse health effects 
are the focus of intense investigation (Vandenberg et al. 2009; Vandenberg et 
al. 2010). On the other hand, DOX is a common chemotherapeutic agent used 
in the treatment of a variety of cancers to which cell resistance can emerge 
(Doublier et al. 2008; Riganti et al. 2009). Plant constituents are a major source 
of bioactive compounds and several pants have been investigated aiming to 
identify potential synergistic effects with DOX (reviewed in Kapadia et al. 2013). 
 
6.3 Materials and methods 
 
Eupatorium cannabinum L. ethanolic extract 
Eupatorium cannabinum L. (Asteraceae) aerial parts were collected in the 
Rossas fields of Arouca village, Portugal, in August during mass flowering. 
Formal identification of plant material was performed by A.P. Paes from “João 
 ______________________________________________________________________ 
______________________________________________________________________ 
85 
 
de Carvalho e Vasconcellos Herbarium” at Instituto Superior de Agronomia 
(Lisboa, Portugal). A voucher specimen was deposited in the same herbarium 
under the number LISI 1503/2013. Plant material was dried and powdered 
using a grinder and ethanolic extract (EcEE) was obtained by soaking the 
material in absolute ethanol for 48 h at room temperature with gentle shaking. 
The extract were filtered and concentrated under vacuum on a rotary 
evaporator at 40º C and stored at -20ºC for further use.  
 
Cellular cultures, reagents and treatments 
HT29 cells were purchased from European Collection of Cell Cultures (ECACC, 
UK) and cultivated in RPMI medium under standard conditions as previously 
described (Ribeiro-Varandas et al. 2013) Before treatments and experiments 
HT29 cells were allowed to stabilize for 24 h in standard medium and further 
cultivated in EcEE supplemented media for 24 h, 48 h or 96 h. Crude ethanolic 
extract was dissolved in ethanol to a final work concentration of 50 mg/ml 
before use and added to the culture media at four different final concentrations 
(0.5 µg/ml, 5 µg/ml, 25 µg/ml and 50 µg/ml). Bisphenol A (Sigma) was freshly 
diluted in ethanol and added to the culture media to the final concentration of 1 
µg/ml (4.4 µM) that corresponds to the established Tolerable Daily Intake (TDI) 
level of 50 ug/kg BW/day (EFSA 2006, 2010) considering an average body 
weight of 70 Kg and daily consumption of 3 litres of preformed water. 
Doxorubicin (DOX) (AppliChem) was dissolved in water at stock concentration 
of 1 mg/ml and added to the culture media to final concentration of 2.5 µg/ml (4 
µM) which corresponds to a therapeutic dosage (Greene et al. 1983). For the 
combined EcEE/BPA or EcEE/DOX exposures, cells were pre-exposed to EcEE 
for 24 h followed by additional 24 h of simultaneous exposure to EcEE and BPA 
or EcEE and DOX. Single 24 h BPA or DOX exposure was carried-out in 
equivalent cell cultures. For evaluation of cell recovery capacity after treatments 
cells were cultivated for additional 72 h in standard culture medium. Negative 
controls were performed for all experiments using cells grown in standard 
culture medium as well as cells grown in medium supplemented with ethanol at 
final concentration of 170 µM, corresponding to the final concentration of 
ethanol used as vehicle for all EcEE concentrations as well as for BPA. 
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Cell viability  
Cell viability was evaluated by CellTiter-Blue assay (Promega) following 
manufacturer’s instructions. Cells were plated on 96-well dishes at a density of 
3.2 × 104 cells/well and after treatments were incubated for 4 h with CellTiter-
Blue Reagent. Additional negative controls were performed in the absence of 
cells to guarantee that the utilized media did not interfere with fluorescence 
readings. Experiments were repeated at least three times with a minimum of 
three replicates per experiment.  
 
DAPI staining, TUNEL assay and immunodetection 
For cytological analysis cells were grown over glass coverslips coated with 
0.2% (v/v) gelatin (Sigma) and after treatments fixed in 4% (p/v) formaldehyde 
in PBS. For evaluation of colony morphology, mitotic index as well as mitotic 
and nuclear anomalies cells were DAPI stained and mounted on glass slides 
with antifade AF1 (Citifluor). DNA damage assessment with TUNEL assay 
(Roche) was performed accordingly to manufacturers´ instructions. 
Immunodetection of H3K9ac and α-tubulin was performed in fixed cells as 
previously described (Ribeiro-Varandas et al. 2013) using the primary 
antidodies anti-acetyl-histone H3(Lys 9) (ab10812, Abcam) and anti-α-Tubulin 
(T9026, Sigma) detected with FITC or Cy3 conjugated secondary antibodies. 
Images were captured using the appropriate excitation and emission filters and 
recorded using an epifluorescence microscope Zeiss Axioskop2 equipped with 
a Zeiss AxioCam MRc5 digital camera. ImageJ software 
(http://rsbweb.nih.gov/ij/) was used for nuclear area measurements. The 
analysis was performed in the pooled results of at least two independent 
experiments with at least two replicates.  
 
cDNA isolation and real-time quantitative PCR 
Transcriptional analysis was performed by quantitative real-time PCR (qRT-
PCR) for the proliferation-associated genes nucleolin (NCL), FOS and p21, for 
the cell cycle related gene AURKA, and the anti-apoptotic gene bcl-xl. The 
specific primers utilized are listed in Table 1, GAPDH and β-actin were used as 
control genes (Ribeiro-Varandas et al. 2013; 2014). Total RNA was extracted 
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from trypsinized cells with the RNAqueous Kit (Invitrogen) following 
manufacturers´ instructions. 3 µg of total RNA was utilized for RNase free 
DNase digestion (RQ1 RNase free DNase, Promega) and first strand cDNA 
synthesis was completed with random primers (DYNAmo cDNA syntesis Kit, 
Thermo Scientific). The resulting cDNA was utilized for qRT-PCR with SsoFast 
Eva Green Supermix (BioRad) utilizing the following conditions: 95 ◦C for 3 min, 
35 cycles (95 ºC for 30 s, 55 ºC for 30 s, 72 ºC for 40 s), and 72 ◦C for 5 min. 
Control PCRs were also performed prior to cDNA synthesis and for all primer 
combinations without template. Experiments were repeated at least three times 
with at least three replicates per cell treatment/primer combination in each 
experiment. Since no significant differences were detected between the two 
reference genes, threshold cycles (Ct) of the target genes were equilibrated 
with the mean Ct of GAPDH and β-actin genes to calculate ∆Ct (∆Ct = Ct target – 
mean Ct GAPDH:β-actin). Gene expression levels were analyzed by calculating 
∆∆Ct (∆∆Ct = ∆Ct treatment – mean ∆Ct control). Results are presented as log2 of 
the mean fold change (2-∆∆Ct) ± standard deviation.  
 
Table 1 - Primers used for qRT-PCR 
Gene Accession na Forward primer (5´→3´) Reverse primer (5´→3´) 
p21  NM_000389 CTGGAGACTCTCAGGGTCGAA CCAGGACTGCAGGCTTCCT 
AURKA  NM_003600 GCTGGAGAGCTTAAAATTGCAG TTTTGTAGGTCTCTTGGTATGTG 
FOS   NM_005252 AGGAGAATCCGAAGGGAAAG  CAAGGGAAGCCACAGACATC  
Bcl-xl  NM_001191.2 TTACCTGAATGACCACCTA ATTTCCGACTGAAGAGTGA 
NCL NM_005381 CCTTCTGAGGACATTCCAAGACA ACGGTATTGCCCTTGAAATGTT 
GAPDH   NM_002046 GAGTCAACGGATTTGGTCGTA GCAGAGATGATGACCCTTTTG 
β-actin  NM_001101 GGTCATCTTCTCGCGGTTGGCCTTGGGGT CCCCAGGCACCAGGGCGTGAT 
a
 GenBank accession numbers (National Center for Biotechnology). 
 
 
Statistical analysis 
Student´s t test was use for statistic analysis of gene transcription, cell viability, 
nuclear area and nuclear fragmentation. No significant differences were 
detected between control and vehicle for all parameters analysed, results are 
shown in relation to control. GraphPad Prism 6 software was used for 
determination of IC50 values. 
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6.4 Results 
 
6.4.1 E. cannabinum ethanolic extract decreases HT29 cell viability. 
Assessment of cell viability was performed to test potential cytotoxic effects of 
E. cannabinum ethanolic extract (EcEE) on HT29 cells. For this, CellTiter-Blue 
assay was utilized and effects of different concentrations of EcEE (0.5 µg/ml, 5 
µg/ml, 25 µg/ml and 50 µg/ml) were evaluated after 24 h, 48 h and 96 h of 
exposure (Figure 1-A). The higher EcEE concentration (50 µg/ml) resulted in 
severe cell viability decrease after 24 h exposure and complete loss of viability 
at subsequent time points analyzed (48 h and 96 h). On the other hand, no 
decrease in cell viability was detected after 24 h or 48 h for the lower EcEE 
concentrations, and a slight increase in fluorescence was observed after 24 h 
and 48 h for 25 µg/ml EcEE. However, after 96 h of exposure significant 
decreases in cell viability were detected for the three lower EcEE 
concentrations, and particularly for 25 µg/ml EcEE (-18.89%, -14.55% and -
73.25% for 0.5 µg/ml, 5 µg/ml and 25 µg/ml, respectively). Taken together, 
these results indicate more severe effects after prolonged exposure. This is 
further shown by IC50 values of 46.75, 44.64 and 13.38 µg/ml for 24, 48 and 96 
h, respectively. To detect possible deferred effects of the EcEE exposure cell 
viability was also evaluated after 72 h of recovery in standard culture media 
(Figure 1-B) revealing a severe decrease exclusively for 48 h exposure to 25 
µg/ml EcEE (-75.59%). To better understand the effects of EcEE immediately 
after 48 h exposure, gene transcription analysis was carried out for three 
proliferation-associated genes, namely nucleolin (NCL), p21 and FOS (Figure 1-
C). Similarly to the cell viability results, no significant differences in transcription 
levels were detected after 48 h exposure to EcEE concentrations equal or lower 
to 5 µg/ml. Conversely, 25 µg/ml EcEE exposure resulted in significant 
differences in mRNA levels of all three genes, corresponding to down regulation 
of both NCL and FOS (Log2 fold change = -0.813 ± 0.248 and -0.741 ± 0.078, 
respectively), and up regulation of p21 (Log2 fold change = 1.393 ± 0.128). 
Evaluation of colony morphology was performed immediately after EcEE 
treatments by DAPI staining. Again, significant alterations in colony morphology 
were detected after exposure to 25 µg/ml EcEE for 48 h, evident as cells being 
more dispersed showing a flattening of cellular aggregates in comparison to 
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controls with no detectable effect for 5 µg/ml EcEE (Figure 1-D) or 0.5 µg/ml 
EcEE (not shown). 
 
 
Figure 1 - EcEE affect cell viability and proliferation (A) Cell viability after 24 h, 48 h 
and 96 h of exposure to distinct concentrations of EcEE and (B) after 72 h recovery in 
EcEE-free medium following 24 h and 48 h treatments. Results are presented as 
percentage over control, **p<0.0001 and *p<0.01. (C) NCL, FOS and p21 differential 
transcription after 48 h exposure to distinct EcEE concentrations. Results are shown as 
mean log2 fold change (2-∆∆Ct) ± standard deviation in relation control, *p<0.0001. (D) 
DAPI stained HT29 colonies after 48 h in control medium and medium supplemented 
with EcEE 5 µg/ml or EcEE 25 µg/ml. All images have identical magnification, bar = 50 
µm. 
 
6.4.2 E. cannabinum ethanolic extract induces alterations in nuclear 
structure and mitotic disruption. 
A detailed cytological analysis was performed for 0.5 µg/ml, 5 µg/ml and 25 
µg/ml EcEE concentrations after 48 h of exposure and again significant nuclear 
alterations were observed exclusively for 25 µg/ml EcEE (Figure 2-A). This was 
obvious as the prominent occurrence of micronuclei and highly condensed 
nuclei (pyknosis) scattered throughout cell aggregates as well as fragmented 
nuclei (karyorrhexis), revealing irreversible nuclear damage. In addition, TUNEL 
assay showed that induction of DNA breaks also occurred after 48 h exposure 
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to 25 µg/ml EcEE treatments although at a much lower level than nuclear 
abnormalities, as many of the abnormal nuclei were not TUNEL positive and in 
positive nuclei labeling was sparse (Figure 2-B). For the two lower EcEE 
concentrations (0.5 and 5 µg/ml) no TUNEL positive nuclei were detected (not 
shown) as observed for control. Importantly, qRT-PCR transcriptional analysis 
of the anti-apoptotic bcl-xl gene revealed that EcEE exposure induced a 
significant up regulation of this gene not only at 25 µg/ml (Log2 fold change = 
0.528 ± 0.243) but also at 5 µg/ml, although to a lesser extent (Log2 fold 
change = 0.158 ± 0.067) (Figure 2-C). Quantification of the nuclear area of non-
pyknotic and non-fragmented DAPI stained nuclei showed a significant increase 
in this parameter in relation to control for cells exposed to 25 µg/ml EcEE but 
not to the lower EcEE concentrations (not shown). The increment in nuclear 
area after the 48 h exposure to 25 µg/ml EcEE corresponded in average to 
48.8% (n > 70 for each growth condition, p < 0.0001 for 25 µg/ml EcEE in 
relation to control) and was accompanied by an evident increase in cellular area 
revealed by α-tubulin immunodetection (Figure 2-D). Moreover evident 
chromatin enrichment in histone H3 acetylated on lysine 9 (H3K9ac) was 
detected also for 48 h 25 µg/ml EcEE (Figure 1-E) whereas no alteration was 
observed for either 0.5 µg/ml or 5 µg/ml EcEE (not shown). The effects of 
exposure to EcEE were further evaluated on mitotic cells after DAPI staining. 
No significant variation was observed in the mitotic index between control, 
vehicle and EcEE independently of the concentration assayed (varying between 
4.57 and 5.94). On the other hand, although mitotic anomalies, particularly 
multipolar metaphases and anaphases, are a common feature of HT29 cells 
and therefore observed both in control and vehicle (6.67% and 11.76% after 24 
h; 6.38% and 10.67% after 48 h, for control and vehicle respectively), the 
percentage of abnormal mitosis increased after exposure to all EcEE 
concentrations (Figures 3-A and 3-B). Although a slight increase of abnormal 
mitosis was already detectable for 0.5 µg/ml EcEE, this effect was greater for 5 
µg/ml EcEE (41% and 44% after 24 h or 48 h, respectively). After exposure to 
25 µg/ml EcEE, most mitotic cells presented abnormalities (80% and 63% after 
24 and 48 h, respectively). Although the frequency of abnormal mitosis was 
greater after 24 h at the higher EcEE concentration, these results clearly 
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indicate that EcEE induces mitotic disruption in a dose dependent manner. 
Interestingly, qRT-PCR analysis revealed a significant down regulation of 
AURKA (Log2 fold change = -0.938 ± 0.146), a gene that encodes a key protein 
for mitotic chromosome segregation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Nuclear organization is disrupted after 48 h of exposure to EcEE 25 µg/ml 
(A) DAPI stained HT29 interphase cells. Nuclear anomalies, namely pyknosis (arrow), 
micronuclei (open arrow head) and karyorrhexis (arrow head) are detectable only for 
25 µg/ml EcEE. The lack of effects induced by EcEE lower concentrations is 
exemplified by 5 µg/ml EcEE. (B) TUNEL positive nuclei (arrow) with sparse labeling 
are detectable for 25 µg/ml EcEE. (C) bcl-xl differential expression after 48 h exposure 
to distinct EcEE concentrations. Results in are shown as the mean log2 fold change (2-
∆∆Ct) ± standard deviation in relation control, **p<0.0001 and *p<0.01. (D) DAPI staining 
(blue) and α-tubulin immunodetection (red in merged images at the bottom) of 
interphase cells after 48 h in control or 25 µg/ml EcEE. Merged images are shown in 
the bottom. (E) Immunodetection of H3K9ac after 48 h in control or EcEE 25 µg/ml 
supplemented medium. Within each experiment all images have identical 
magnification, bar = 5 µm. 
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Figure 3 - EcEE exposure induces mitotic disruption. (A) DAPI stained abnormal 
mitotic cells after EcEE exposure showing (i) defective chromosome congression, (ii) 
tripolar and (iii) tetrapolar metaphases and (iv) tripolar anaphase with chromosome 
bridges, bar = 5µm. (B) Percentage of abnormal mitosis after 24 h and 48 h exposure 
to distinct concentrations of EcEE; the total number of mitotic cells scored to calculate 
the percentage of abnormal mitosis is shown in brackets. (C) AURKA differential 
transcription after exposure to 48 h of EcEE. Results are shown as the mean log2 fold 
change (2-∆∆Ct) ± standard deviation in relation control, *p<0.0001. 
 
6.4.3 E. cannabinum ethanolic increases Bisphenol A induced mitotic 
disruption. 
Interactions between EcEE and the environmental pollutant BPA at reference 
level (1 µg/ml) were evaluated. Co-exposure to EcEE and BPA did not affect 
cell viability immediately after treatments, as no significant differences were 
detected in relation to control (Figure 4-A). After 72 h recovery in standard 
medium a severe decrease in cell viability (-93.48%) was exclusively observed 
for 25 µg/ml EcEE/BPA (Figure 4-A) being even stronger than that observed for 
25 µg/ml EcEE alone (Figure 1-B).  
Cytological evaluation of mitotic disruption after DNA DAPI staining (Figure 4-B) 
revealed that BPA exposure alone increased the level of mitotic anomalies to 
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20.5%. Interestingly, a stronger effect of BPA co-exposure was observed for the 
lowest EcEE concentration assayed (0.5 µg/ml) resulting in 41% of abnormal 
mitosis (Figure 4-B) compared to 25% observed for EcEE alone (Figure 3-B). In 
contrast, no evident effect of BPA was detected for the intermediate EcEE 
concentration as an identical level of 44% was detected for 5 µg/ml EcEE alone 
or in combination with BPA. Co–exposure to the higher EcEE concentration (25 
µg/ml) and BPA resulted in a particular high level of mitotic anomalies (75%), 
although the difference in relation to EcEE alone (63%) was smaller than that 
observed for the lower EcEE concentration.  
 
 
 
Figure 4 - EcEE interacts with BPA at reference level (A) Cell viability after co-
exposure to BPA (1 µg/ml) and distinct EcEE concentrations and subsequent 72 h 
recovery in standard medium. Results are presented as percentage over control, 
*p<0.001. (B) Percentage of mitotic anomalies after 48 h culture in standard medium 
(control) or medium supplemented with ethanol (vehicle), BPA or EcEE at distinct 
concentrations in combination with BPA. The total number of mitotic cells scored to 
calculate the percentage of abnormal mitosis is shown in brackets. 
 
6.4.4 Cytotoxic effects of Doxorubicin are enhanced by E. cannabinum. 
Potential interactions between different concentrations of EcEE and the 
chemotherapeutic drug doxorubicin (DOX) at a therapeutic concentration of 2.5 
µg/ml were investigated. Immediately after exposure, DOX alone resulted in a 
slight decrease in cell viability (-4.15%) (Figure 5-A). Interestingly, the loss of 
cell viability was significantly more pronounced after co-exposure to EcEE/DOX 
for all EcEE concentrations (-10.03%, -19.88% and -18.67% for 0.5 µg/ml, 5 
µg/ml and 25 µg/ml, respectively) (Figure 5-A) contrasting with the lack of 
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effects observed for 48 h exposure to EcEE alone (Figure 1-A). Recovery 
experiments showed that the effects of both DOX and 25 µg/ml EcEE/DOX 
have long lasting negative effects on viability, apparent as prominent decreases 
in cell viability after 72 h recovery in standard medium in relation to what was 
observed immediately after exposure (Figure 5-A). After recovery, EcEE 25 
µg/ml/DOX exposure resulted in an even more pronounced loss of cell viability 
(-93.95%) than that observed for exposure to 25 µg/ml EcEE alone (Figure 1-B). 
Conversely, for the lower EcEE concentrations, no significant differences were 
detected between exposure to DOX alone and in combination with EcEE 
(Figure 1-B). 
Cytological analysis after DAPI staining showed a complete absence of cells at 
mitosis after exposure to DOX alone or in combination to EcEE, independently 
of the EcEE concentration. Conversely both pyknotic cells and fragmented 
nuclei were observed after exposure to DOX alone or in combination to EcEE 
(Figure 5-B). Since identical nuclear alterations were also observed after single 
exposure to 25 µg/ml EcEE (Figure 2-E), the levels of nuclear fragmentation 
were compared between single exposure to 25 µg/ml EcEE or DOX alone and 
the combination of both (Figure 5-C). The results obtained revealed that the 
induction of nuclear fragmentation is significantly higher for 25 µg/ml EcEE/DOX 
combined exposure (20.28%) than for either DOX (7.63%) or 25 µg/ml EcEE 
(8.89%) alone.  
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Figure 5 - EcEE has synergistic effects with DOX at a therapeutic dose. (A) Cell 
viability after co-exposure to DOX (2.5 µg/ml) and distinct EcEE concentrations and 
subsequent 72 h recovery in standard medium. Results are presented as percentage 
over control, the level of significance in relation to DOX alone is indicated by horizontal 
brackets, **p<0.0001 and *p<0.01. (B) DAPI stained cell after co-exposure to EcEE 25 
µg/ml/DOX illustrating the occurrence of (i) micronuclei (arrow head) and pyknotic 
nuclei (arrow) and (ii) fragmented nuclei (arrows), bar = 5 µm. (C) Percentage 
fragmented nuclei after exposure to EcEE 25 µg/ml or DOX alone and the combination 
of both. Total number of cells analyzed is shown in brackets, **p<0.0001 and *p<0.03 
in relation to EcEE 25 µg/ml or DOX alone.  
 
6.5 Discussion 
 
Eupatorium cannabinum L. is a commonly utilized plant for alternative and/or 
complementary medicine treatments (Jaric et al. 2007) including as an 
anticancer agent (Roeder and Wiedenfeld 2013). Although cellular effects of 
particular phytochemicals known to be present in E. cannabinum have been 
previously described, to our knowledge this is the first study that evaluates the 
cytotoxic potential of E. cannabinum extracts on human cancer cells. Here we 
demonstrated that E. cannabinum ethanolic extract (EcEE) has cytotoxic effects 
on HT29 colon cancer cells in a time and dose dependent manner. IC50 were 
similar after 24 and 48 h (46.75 and 44.65 µg/ml, respectively) but considerably 
lower (13.38 µg/ml) after 96 h of exposure. Cytotoxic activity has also been 
demonstrated for extracts from other Eupatorium species. For E. perfoliatum 
ethanolic extract, IC50 values between 12 and 14 µg/ml were obtained after 24h 
exposure in three distinct mammalian cell lines (Habtemariam and Macpherson 
2000). In MCF7 breast cancer cells a time dependent effect was also observed 
for E. odoratum ethyl acetate extract (IC50 of 65.72, 83.88 µg/ml and 92.84 
 ______________________________________________________________________ 
______________________________________________________________________ 
96 
 
µg/ml for 24, 48 and 72 h, respectively) while for acetone extract higher IC50 
values were obtained but without a direct correlation with exposure time (133.9, 
163.0 and 147.8 µg/ml for 24, 48, and 72 h respectively) (Harun et al. 2012). 
The immediate cytotoxicity here observed for EcEE is lower than that observed 
for E. perfoliatum ethanolic extract but higher than that observed for ethyl 
acetate and acetone extracts from E. odoratum. Interestingly the time 
dependent increase in cytotoxicity of EcEE was only detected for the longer 
exposure time (96 h).  Moreover a deferred effect on cell viability was detected 
after 48 h exposure to EcEE at 25 µg/ml. This was also associated with 
disruption of cell colony three-dimensional arrangement was associated with a 
generalized increase in nuclear area and H3K9 hyperacetylation. Relevantly, 
gene transcription analysis revealed a significant reduction in the mRNA levels 
of FOS, which encodes for a nuclear protein from AP-1 transcription factor 
complex, and nucleolin (NCL) the most profuse non-ribosomal protein of the 
nucleolus. Both FOS and nucleolin are involved in the regulation of cell 
proliferation (Mongelard and Bouvet 2007; Shaulian and Karin 2002) as their 
decreased expression has been related with reduced proliferation capacity of 
cancer cells including colon cancer cell lines (Pandey et al. 2012; Turck et al. 
2004). On the other hand, exposure to EcEE (25 µg/ml, 48 h) also resulted in 
the up regulation of p21, a cyclin-dependent kinase inhibitor which is a major 
regulator of the cell cycle (Xiong et al. 1993). It was previously shown that 
histone hyperacetylation induces p21 over expression (Fang and Lu 2002). In 
colon cancer cells inhibition of histone deacetylation results in both up 
regulation of p21 (Druesne et al. 2004), and induction of G2/M cell cycle arrest 
(Robert et al. 2001). Relevantly, cell reduction capacity depends on the cell 
cycle being higher at G2/M (Conour et al. 2004). Considering that the cell 
viability assay used is based on the resazurin reduction and that overall our 
results were incompatible with EcEE induction of cell proliferation, the slight and 
transient augment of fluorescence detected after 24 h and 48 h of exposure to 
25 µg/ml EcEE was also suggestive of cell arrest at G2 or M. Moreover, the 
increase of abnormal mitotic cells after exposure to EcEE is also suggestive of 
a mitotic block. This phenotype was accompanied by a significant down 
regulation of Aurora A transcription, what is consistent with previous results 
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showing that decreased Aurora A levels are associated with mitotic catastrophe 
and consequent cell death (Kimura et al. 2013). Induction of cell death after 48 
h exposure to 25 µg/ml was evident by the prominent occurrence of pyknotic 
and fragmented nuclei, characteristic of both apoptotic as well as necrotic cells, 
and supports the marked loss in cell viability observed after recovery. This was 
moreover associated with transcriptional up regulation of the anti-apoptotic 
gene bcl-xL suggesting a non-apoptotic cell death pathway (Michels et al. 2013) 
also supported by limited occurrence of DNA breaks. These observations 
together with the increase in the cell size is compatible with a necrotic cell death 
or necroptosis, a process which acts as backup death-inducing mechanism 
when apoptosis is inhibited (Cerella et al. 2014).  
Cytostatic activity was previously described for compounds identified in E. 
cannabinum extracts namely the sesquiterpene eupatoriopicrin (Rucker et al. 
1997) and the flavonoids centaureidin, jaceosidin and hispidulin (Zhang et al. 
2008). Severe decrease of tumour cell survival in vitro was associated with 
eupatoriopicrin concentrations ranging from 1-10 µg/ml (Woerdenbag et al. 
1989a; Woerdenbag et al. 1989b) which was correlated with induction of DNA 
damage (Woerdenbag et al. 1989b). Also anti-proliferative effects on distinct 
cancer cell lines have been described for centaureidin concentrations below 1 
µg/ml (Forgo et al. 2012) as well as for jaceosidin in the concentration range of 
20-50 µg/ml (Lee et al. 2013) and hispidulin for 4-30 µg/ml (Gao et al. 2013). 
Relevantly, both jaceosidin (Lee et al. 2013) and hispidulin (Yu et al. 2013) 
effects were associated with increased p21 expression. The results now 
obtained indicate that the anti-proliferative potency of EcEE is similar to some of 
its individual constituents in particular eupatoriopicrin, jaceosidin and hispidulin 
without marked induction of DNA damage suggesting a combined action of 
distinct compounds.   
Importantly, EcEE combined exposures with DOX at therapeutic concentration 
resulted in a clear enhancement of cytotoxic effects evident as combined 
treatments significantly decreased HT29 cell viability immediately after 
exposure, also observed for the lower EcEE concentration that per se did not 
affect cell viability. This was accompanied by increased nuclear fragmentation 
and reduced cell survival after recovery resulting in almost total loss of cell 
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viability. DOX is a commonly utilized antineoplastic drug that acts in tumour 
cells by induction of apoptosis (Gamen et al. 2000). Nevertheless different types 
of cell death can occur simultaneously, independently or through partially 
common pathways (reviewed in Cerella et al. 2014). The severe decrease in 
cell viability observed after combined exposure to DOX and EcEE can thus 
result from induction of distinct cell death mechanisms. On the other hand 
therapeutic concentrations of DOX induces cell arrest at G2/M and/or G1/S 
checkpoints (Bar-On et al. 2007; Lupertz et al. 2010). The results obtained 
show that EcEE does not counteract DOX-induced cell cycle arrest. 
Considering that DOX acts by induction of apoptosis (Gamen et al. 2000) and to 
which cell resistance can emerge (Doublier et al. 2008; Riganti et al. 2009) our 
data substantiates potential adjuvant EcEE properties in chemotherapeutic 
approaches (Koehler et al. 2014). 
On the other hand, no immediate effect on cell viability was associated with co-
exposure to EcEE and the synthetic phenolic compound BPA. However, cell 
recovery capacity after 48 h exposure to 25 µg/ml EcEE was decreased by the 
presence of BPA. Additionally, EcEE/BPA combined exposures resulted in 
increased mitotic anomalies in relation to either BPA or EcEE alone for 25 µg/ml 
EcEE but also for 0.5 µg/ml EcEE. BPA is characterized as an aneugenic 
chemical (Johnson and Parry 2008) capable to interfere with cell division 
mechanisms even at very low concentrations (Ribeiro-Varandas et al. 2013). 
Nonetheless BPA is widely used in a variety of consumer products leading to a 
generalized human exposure and its risks remain highly controversial 
(Vandenberg et al. 2010). The present results raise the possibility that adverse 
BPA effects could be enhanced by interactions with other chemicals, an aspect 
that remains largely unknown and has barely been addressed.  
6.6 Conclusion   
 
E. cannabinum has been utilized as a medicinal plant for alternative and/or 
complementary medicine, however the effects or the mode of action of full 
extracts have not been evaluated at the cellular level. The present work 
demonstrates that E. cannabinum ethanolic extract has potent cytotoxic activity 
against HT29 colon cancer cells associated with mitotic disruption and cell 
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death without marked evidences of DNA damage. Relevantly E. cannabinum 
extract exhibits synergistic effects with doxorubicin in the induction of HT29 cell 
death indicating its potential use in alternative or complementary therapeutic 
strategies. On the other hand, the results show also that E. cannabinum can 
increase aneugenic effects of the environmental pollutant BPA, drawing 
attention to the possibility that BPA adverse effects may be potentiated by 
interaction with other chemicals. 
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7 General Discussion 
 
Presently the scientific community debates with a great controversy between 
the established TDI level for BPA (EFSA 2006, 2010), estimate intake levels 
based on migration values (WHO 2010) and biomonitoring studies on detected 
internal levels of unmetabolized BPA (Vandenberg et al. 2010). BPA effects 
have been extensively investigated in human cell lines associated with 
estrogenic receptors signalling pathways. Several lines of evidence established 
that this EDC promotes variable cellular responses frequently associated to cell 
type specificities. However the effects of BPA on human cells which are in 
continuous direct contact to this chemical in vivo, specifically digestive tract 
cells and vascular endothelial cells are mostly unknown. In this work the effects 
of two BPA concentrations, namely 10 ng/ml (44 nM), i.e. in the range detected 
in human blood at environmental exposures (Vandenberg et al. 2010) and 1 
µg/ml (4.4 µM) associated to occupational exposure (He et al. 2009; Li et al. 
2010) were evaluated in two cell types. Human Colon Adenocarcinona cell line 
(HT29) was selected as this type of cancer is one of the most common causes 
of death in industrialized countries (WHO 2014) and Human Umbilical Vein 
Endothelial Cells (HUVEC) was selected as representative of primary vascular 
endothelial cells tissues which undergo senescence in culture (Khaidakov et al. 
2011). Both HT29 and HUVEC express the classical ERβ but are negative for 
ERα (Arai et al. 2000; Campbell-Thompson et al. 2001; Matthews et al. 2001; 
Toth et al. 2008). In relation to the membrane bound estrogen receptor GPR30, 
for which BPA has considerable high affinity (Thomas and Dong 2006), it is not 
expressed in HUVEC in standard culture conditions (Takada et al. 1997) ant it is 
demonstrated here its expression in HT29 cell line. Previously GPR30 
expression in a ERβ-positive and ERα-negative cell line was correlated with 
BPA increased cell proliferation (Bouskine et al. 2009). However, we did not 
observe any BPA effect on cellular proliferation in either HT29 or HUVEC, 
indicating that BPA induced proliferation in GPR30-positive cell is dependent on 
cell type.  
Interestingly, despite the deferential expression of GPR30, our results show that 
overall HUVEC were more susceptible to BPA exposure than HT29 cells. We 
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demonstrate for the first time that low-dose exposure to BPA increases the 
proportion of micronuclei formation in HUVEC, what is probably associated with 
spindle disruption, as previously reported for higher BPA concentrations in other 
cell lines (Nakagomi et al. 2001; Parry et al. 2002). HUVEC also show higher 
sensitivity to BPA-induced nucleolar disruption evidenced by altered nucleolar 
architecture and organization accompanied by variation on intranucleolar 
epigenetic marks H3K9me2 and H3K4me3, associated with transcriptional 
silencing and competence, respectively (Bartova et al. 2010; Hon et al. 2009). 
Although the global nuclear distribution pattern of these epigenetic marks is not 
affected by BPA exposure in both HT29 and HUVEC, induced modifications at 
specific genes cannot be excluded, particularly considering that BPA is known 
to affect the transcriptional expression of several genes involved in major 
cellular processes in different cell lines (Boehme et al. 2009; Bredhult et al. 
2009; Buterin et al. 2006; Naciff et al. 2010). In fact, our transcriptional analysis 
also reveal HUVEC higher sensitivity to BPA since more pronounced effects on 
expression patterns of genes encoding for proteins involved in chromosome 
segregation as well as ribosome subunit biogenesis were observed. Additionally 
general transcription analysis based in the relative transcription of two LINE-1 
related sequences shows a time and dose dependent effect of BPA on HUVEC 
whereas in HT29 cell line the response to BPA is lost with prolonged exposure.  
The lower responsiveness of HT29 cells to BPA may be correlated with intrinsic 
characteristics of cancer cells which are described to be more insensitive to 
external stimulus (Hanahan and Weinberg 2011). Nevertheless it is important to 
refer that BPA-induced alterations in HT29 cells, namely transcription 
deregulation of LINE-1 related sequences and alteration of nucleolar 
morphology, are observed exclusively for the lower BPA concentration assayed. 
Hence our results suggest that BPA action in colon cancer cells may follow a 
nonmonotonic dose response (NMDR), what may be a common feature of 
natural hormones as well as EDCs (reviewed in Vandenberg et al. 2012). On 
the other hand, the results obtained from gene transcription and cell viability 
analysis show that continuous exposure to BPA interferes with HUVEC aging 
processes..  HUVEC are in vitro model for atherosclerosis pathogenesis 
(Khaidakov et al. 2011) and epidemiologic studies revealed a positive 
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correlation between BPA exposure and vascular diseases (Lind and Lind, 2011; 
Melzer et al., 2012; Melzer et al., 2010). Overall, our data indicate that BPA may 
play a role in atherosclerosis induction corroborating a potential impact on aging 
processes as previously suggested for mammary cells (Qin et al. 2012).  
In relation to colon cancer cells it is important to take into consideration that 
digestive tract cells contact with ingested BPA prior to its conjugation what 
contributes to the overall cell exposure. Additionally the increase of extracellular 
β-glucuronidase levels in most solid tumors microenvironment (Tranoy-
Opalinski et al. 2014) leads to a high level of uncertainty regarding BPA 
exposure. BPA potential interactions with chemotherapeutic drugs is an 
extremely poorly investigated issue, however in breast cancer cells it has been 
suggested that BPA is able to antagonize cytotoxic effects of distinct commonly 
used antineoplasic drugs including doxorubicin (DOX) (LaPensee et al. 2009). 
Interestingly, the present results show that in colon cancer cells BPA at a 
concentration derived from the TDI is able to interfere with DOX at therapeutic 
relevant level by antagonizing DOX-induced transcriptional effects on key genes 
involved in cancer biology. Surprisingly, these DOX-antagonistic effects of BPA 
are not observed for a 100-fold lower DOX concentration nor BPA per se 
induces major alterations on the transcription levels of the genes analyzed. 
Taken together these results emphasize the urge to address BPA interactions in 
the context of chemotherapy and raise important questions regarding BPA 
mode of action and consequences of the interactions on cancer cell fate. 
In this work BPA interactions with Eupatorium cannabinum extract were also 
investigated showing that BPA aneugentic effects are increased by co-
exposure. Eupatorium cannabinum is a medicinal plant that has long been 
utilized in alternative and/or complementary medicine (Jaric et al. 2007) 
including as an anticancer agent (Roeder and Wiedenfeld 2013) however, the 
cellular effects of its extracts were never assessed. The results obtained 
demonstrate a potent cytotoxic activity of E. cannabinum against colon cancer 
cells. Additionally, E. cannabinum extract also show synergistic effects with 
DOX in the induction of HT29 cell death supporting its potential use for cancer 
alternative or complementary therapeutic strategies.  
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Altogether the present work substantiates increasing concerns regarding the 
potential adverse effects of BPA low-dose exposures on human health. This is 
evident as we clearly established the potential genotoxic aneugenic effect of 
this chemical in vascular cells and supported previous epidemiologic 
correlations between circulating BPA levels and age-related pathologies (Lind 
and Lind 2011; Melzer et al. 2010; Melzer et al. 2012). Additionally we have 
also demonstrated the importance of addressing the effects of BPA drug-
interaction, particularly in the context of chemotherapy and chemoresistance, 
and raise the prospect that BPA effects may be potentiated by interaction with 
other compounds.  
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9 List of abbreviations 
 
AURKA ................................... Aurora A kinase gene 
BBE ......................................... Bovine Brain Extract  
bcl-xl ....................................... B-cell lymphoma-extra large gene 
BPA ......................................... Bisphenol A 
BSA ......................................... Bovine Serum Albumin 
CDCA8 .................................... Cell Division Cycle Associated 8 gene 
cDNA ...................................... complementary DNA 
Ct ............................................ Threshold cycles  
Cy3 ......................................... Cyanine 3 
DAPI ....................................... 4',6-diamidino-2-phenylindole 
DES ........................................ Diethylstilbestrol 
DFC ........................................ Dense Fibrillar Component 
DNA ........................................ DeoxyriboNucleic Acid 
DNase ..................................... deoxyribonuclease 
DOX ........................................ Doxorubicin 
E2............................................ 17 β- estradiol or oestradiol 
EC50 ........................................ Concentration for 50% of Maximal Effect 
ECACC ................................... European Collection of Cell Cultures  
EcEE ....................................... Eupatorium cannabinum ethanolic extract  
EDC(s) .................................... Endocrine Disrupting Chemical(s) 
EFSA ...................................... European Food Safety Authority 
(US)EPA ................................. (U.S.) Environmental Protection Agency 
ERb ......................................... Estrogen receptor beta 
ERα ......................................... Estrogen receptor alpha    
FBS ......................................... Fetal Bovine Serum 
FC ........................................... Fibrillar Centre 
FISH ........................................ Fluorescent in situ Hybridazation  
FITC ........................................ Fluorescein isothiocyanate 
g .............................................. Standard gravity 
GAPDH ................................... Glyceraldehyde 3-phosphate dehydrogenase gene 
GC........................................... Granular Component 
GlutaMAX ............................... L-Glutamina  
GPR30 .................................... G protein-coupled receptor 30 
H2O2 ............................................................. Hydrogen peroxide 
H3K4me3 ................................ Histone H3 tri-methylated on lysine 4 
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H3K56ac ................................. Histone H3 acetylated on lysine 56 
H3K9ac ................................... Histone H3 acetylated on lysine 9 
HbA1c ..................................... Glycated hemoglobin 
HD ........................................... High Dosages 
HEPES .................................... 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hrs or h, min, sec .................... hours, minutes, seconds  
HT29 ....................................... Human Colon Adenocarcinona cell line HT29 
HUVEC ................................... Human Umbilical Vascular Endothelial Cells 
IgG .......................................... Immunoglobulin G 
Kg, g, mg, µg, ng, pg .............. Kilogram, gram, milligram, microgram, nanogram, picogram 
l or L, ml, µl ............................. litres, millilitres, microlitres 
LD ........................................... Low Dosages 
LOAEL .................................... Lowest Observable Adverse Effect Level 
log ........................................... logarithm 
M, mM, µM,  nM. pM .............. Molar, miliMolar, microMolar, nanoMolar, picoMolar 
miRNA .................................... microRNA 
mRNA ..................................... messenger RNA 
NHANES ................................. National Health and Nutrition Examination Survey 
NMDR ..................................... Nonmonotonic Dose Responses 
NOAEL .................................... No Observable Effect Level 
NOR ........................................ Nucleolar Organizing Regions  
NTP ......................................... National Toxicology Program 
ºC ............................................ degree Celsius  
PBS ......................................... Phosphate Buffered Saline 
PBST ...................................... Phosphate Buffered Saline Tween 
PVDF ...................................... Polyvinylidene difluoride 
qRT-PCR ................................ quantitative Real Time Polymerase Chain Reaction 
rDNA ....................................... ribossomal DNA 
RfD .......................................... Oral Reference Dosage 
RNA ........................................ RiboNucleic Acid 
RNase ..................................... Ribonuclease 
rRNA ....................................... ribosomal RNA 
SDS ........................................ Sodium Dodecyl Sulphate 
SGOL2 .................................... Shugoshin-like 2 gene 
TDI .......................................... Tolerable Daily Intake 
Tm ........................................... melting Temperature 
TUNEL .................................... Terminal deoxynucleotidyl transferase dUTP nick end 
labeling 
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v/v, w/v .................................... Volume per Volume, weight per volume 
WHO...................................... World Health Organization 
α- tubulin ................................. alpha tubulin 
β-actin ..................................... Beta actin 
γ-tubulin .................................. gama Tubulin 
∆ .............................................. Difference    
µm, nm .................................... micrometer, nanometre  
µmol, nmol .............................. micromole, nanomole 
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